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RÉSUMÉ 
Les accidents vasculaires cérébraux, le cancer et la maladie d’alzheimer sont les 
principales causes de décès au Canada. Les lésions nerveuses ou les nerfs endommagés dans le 
système nerveux central peuvent détruire la qualité de vie des survivants, présentent de grands 
couts pour la société et peuvent entraîner la mort. Il n’existe actuellement aucun traitement 
efficace encore pour aider à la régénération des tissus nerveux.  
 
Les stratégies de régénération des tissus nerveux ont été étudiées, cependant, de 
nombreuses limites ont été rencontrées. Par exemple, l'injection directe de cellules souches 
neuronales dans le système nerveux central a donné lieu à la formation de tumeurs. L'injection 
directe de facteurs de croissance n’a révélé aucun bénéfice avant sept jours de traitement continu. 
En outre, l'encapsulation des facteurs de croissance a été précédemment étudiée et possède des 
inconvénients majeurs. Des limites telles que, la difficulté à maintenir leur livraison à long terme 
sur une gamme de concentration définie, leur courte demi-vie ainsi qu’une courte distance de 
migration ont été observées. La production in situ et la distribution de facteur de croissance par 
l’intermédiaire de cellules telles que les fibroblastes modifiés génétiquement pour exprimer le 
BDNF ainsi que les cellules fabriquées en coculture ont aussi démontré des inconvénients 
majeurs.  En effet l’immunosuppression était constamment requise et le taux de survie des 
cellules très faible. 
 
Les biomatériaux tels que les hydrogels ont été largement étudiés et présentent des 
difficultés de manipulations, une faible adhérence, des couts élevés, des difficultés à incorporer 
des médicaments sur leur structure ainsi que de présenter des difficultés lors de leurs 
stérilisations. 
 
Cette étude vise donc à optimiser les stratégies de régénération des tissus nerveux 
existants. Les biomatériaux électrofilés ont montré des résultats prometteurs dans la littérature en 
raison de leur porosité, haut rapport surface-volume, interconnexion des pores ainsi que de leur 
topographie imitant la matrice extracellulaire (ECM) du cerveau. Ces biomatériaux électrofilés 
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ont donc été utilisés dans ce projet. Le procédé d'électrofilage a été utilisé dans cette étude afin 
d'obtenir des fibres dans la gamme nanométrique présentant une topologie à haute porosité, le 
diamètre des fibres idéales ainsi qu’une résistance mécanique adéquate. L’acide poly lactique-L 
(PLLA) est étudié dans cette recherche;  il s'agit d'un polymère couramment utilisé dans 
l'ingénierie tissulaire neurale étant donné qu'il est autorisé par la FDA et a été utilisé sous la 
forme de nanofibres électrofilées. 
 
Des études antérieures ont utilisé d'autres protéines pour l'immobilisation tels que la 
laminine et le collagène. Ces résultats, cependant, n'étaient pas prometteurs et nécessitaient 
l'addition de facteurs de croissance dans les médias. Par conséquent, dans ce travail, les 
nanofibres de PLLA électrofilées ont été optimisées par greffage de manière covalente du facteur 
de croissance épidermique (EGF) puisque EGF a montré des résultats prometteurs dans des 
études précédentes.  
 
 Les nanofibres de PLLA électrofilées ont d'abord été fonctionnalisées avec polyallylamine 
pour introduire des groupes amine. Ensuite, le greffage de l'EGF par l'intermédiaire d'un ester de 
glycol de bis-N-succinimidyle pentaéthylène (PEG) espaceur est effectué. Le substrat est resté 
physiquement intact et le diamètre moyen de fibres ainsi que la porosité est restés inchangés 
après la fonctionnalisation de groupes d’amine. Ceci est en contraste frappant avec les protocoles 
d'amination se fondant sur un traitement au plasma qui a rapporté une dégradation du PLLA ou 
aminolyse au moyen de la petite molécule ethlynediamine (EtDA). 
 
Des cellules souches d’ingénérie ressemblant à des cellules souches neuronales (NSLC) 
ont ensuite été ensemencées sur les substrats modifiés et se sont avérées viables jusqu'à 14 jours.  
Leur prolifération ainsi que leur propagation ont été observées. L'adhérence cellulaire et la 
prolifération sont supérieures lorsque les substrats ont été greffés avec de l'EGF en comparaison à 
des substrats qui ont été seulement aminés. Comme témoin positif, la prolifération des NSLC a 
été caractérisée sur des nanofibres de laminine dans du milieu dépourvu de EGF. Aucune 
différence significative dans la prolifération des cellules entre les substrats de type EGF greffé et 
le témoin positif n’a été observée. Par conséquent, ce nouveau biomatériau fonctionnalisé et 
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greffé du EGF démontre une adhésion cellulaire efficace, une prolifération ainsi que la viabilité 
des cellules jusqu'à 14 jours et présente une avenue prometteuse dans le traitement de la 
régénération de cellules souches. 
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ABSTRACT 
Damaged nerves and nerve injuries in the Central Nervous System (CNS) diminish the 
quality of life of survivors, are costly to society, and can cause death. Strokes, cancer, and 
Alzheimer’s Disease (AD) are the leading causes of death in Canada. There is currently still no 
efficient treatment to aid in the neural tissue regeneration of damaged nerve cells.  
Previous nervous tissue regeneration strategies have been studied, however, many 
limitations were encountered. For example, direct injection of neural stem cells into the central 
nervous system (CNS) has resulted in tumor formation. Direct injection of growth factors showed 
no benefits until after seven days of continuous treatments. Furthermore, the encapsulation of 
growth factors was previously studied and demonstrated major drawbacks. Some limitations, 
such as the difficulty to maintain long-term delivery within a defined concentration range, as well 
as the short half-life of the growth factors and short migration distance were observed. 
Additionally, the in situ production and delivery of growth factors using cells, such as the 
transplantation of genetically modified fibroblasts to express BDNF, as well as the co-culturing 
of cells have also seen some drawbacks. Immune suppression was constantly needed and low cell 
survival rate was observed. Furthermore, biomaterials such as hydrogels have been widely 
studied and proved to be difficult to handle and sterilize, load drugs and nutrients, are non-
adherent, and expensive. 
This study thus aims at optimizing existing nervous tissue regeneration strategies. 
Electrospun biomaterials have shown promising results in literature due to its high porosity, high 
surface area-to-volume ratio, interconnected pores, and topography that mimic extra cellular 
matrix (ECM) in the brain. The electrospinning process was used in this study to obtain the 
desired qualities mentioned, as well as to obtain fibers in the nano-metric range. Poly L-lactic 
acid (PLLA) is a polymer commonly used in neural tissue engineering, since it is FDA-approved 
and was used as a form of electrospun nanofibers in this study.  
Previous studies have used other proteins for immobilization such as laminin and 
collagen. These results, however, were not promising and most often required the addition of 
growth factors in the media as well. Therefore, in this work, the electrospun PLLA nanofibers 
were optimized by covalently grafting epidermal growth factor (EGF) since EGF has shown 
promising results in previous studies.  
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The electrospun PLLA nanofibers were first functionalized with polyallylamine to 
introduce amine groups, before EGF grafting via a bis-N-succinimidyl-pentaethylene glycol ester 
(PEG) linker. The substrate remained physically intact, the average fiber diameter (AFD) and 
porosity also remained unchanged following amine functionalization. This is in stark contrast 
with amination protocols relying on plasma treatment that has been reported to degrade PLLA or 
aminolysis using the small molecule ethylenediamine (EtDa).  
Engineered neural stem-like cells (NSLC) were then seeded onto the modified substrates 
and were shown to be viable up to 14 days, while proliferating and spreading. Cell adhesion and 
proliferation was improved when substrates were grafted with EGF, when compared to substrates 
that were only aminated. As a positive control, NSLC proliferation was also characterized on 
laminin-coated mats in EGF-free medium where no significant differences in cell proliferation 
were observed between the EGF-grafted substrates and the positive control. Therefore, this new 
functionalized and EGF-grafted biomaterial has achieved efficient cell adhesion, proliferation as 
well as cell viability for up to 14 days and has promising use in stem cell regeneration therapy.  
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INTRODUCTION 
Strokes, cancer, trauma, degenerative diseases in the brain (ex. Parkinson’s (PD) and 
Alzheimer’s diseases (AD)), and nerve injuries are some of the many sources of damage or 
diseases inflicting change in the nervous system that cause cell death. They can destroy the 
quality of life of survivors, are costly to society and are the leading causes of death and injuries in 
North America. [1] For example, 16 million first-ever strokes occur annually worldwide causing 
5.7 million deaths with an estimated cost of $65.5 billion in 2008 in the United States only. [2] 
1.4 million Americans endure brain injuries annually of which 50,000 patients die. [1]   
It is widely known that when damaged, there is almost no regeneration or repair of cells 
that occur in the central nervous system (CNS) since the neuron’s cell body has been affected 
(unlike in the peripheral nervous system (PNS) where injured axons are able to self-repair and 
restore function). Damaged axons in the PNS regenerate and recover by proliferating Schwann 
cells and phagocytosing myelin by macrophages or monocytes. [1] Damaged neurons in the CNS 
(brain and spinal chord), however, have difficulty in restoring function due to the lack of 
Schwann cells. Schwann cells are glial cells present in the PNS; they contain neurotrophic and 
growth factors that form myelin sheaths on axons. They range in length from 220-400 
micrometers with a thickness of 2-5 micrometers. [3] In a cross-section (Figure 1-1), several 
unmyelinated axons are embraced by Schwann cells, while surrounded by basal lamina. This 
complex structure is the result of overlap and regrouping of adjoining Schwann cells. [3] 
Furthermore, the CNS lacks macrophages and monocytes, therefore are unable to clear the 
myelin debris when an axon injury occurs. Additionally, after CNS injury, glial scar tissue form 
due to the presence of astrocytes and act as a barrier to regenerating neurons. Inhibitory 
molecules such as myelin-associated glycoprotein (MAG) and oligodendrocyte myelin 
glycoprotein (OGmp) are also present in the CNS that inhibits axon regeneration. [4-8] A 
schematic diagram of CNS and PNS injury is shown in Figure 1-2. [9] 
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Figure 1-1: Cross-section of unmyelinated axons being embraced by Schwann cells. Axons are 
marked by numbers and Schwann cells by letters. A capital letter denotes a Schwann cell in 
contact and a lower case letter a Schwann cell out of contact with an axon. [3] 
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Figure 1-2: Schematic representation comparing injury at the CNS vs. PNS. [9] 
 
The possibility of using biomaterials as a cell-scaffold construct in neural tissue 
engineering has been explored as an alternative to current therapeutic strategies. The ideal 
material should have excellent cytocompatible properties, otherwise they may induce severe 
inflammation or infection and may fail to improve neural cell growth. [1] Electrospun nanofibers 
have shown to be cytocompatible while stimulating cell proliferation. [10, 11] Haibin et al [11] 
have seeded  MC3T3-E1 cells (cells commonly used to assess cytotoxicity of potential substrates 
for cell growth) on poly lactic acid (PLA) fibrous scaffolds, and after a 48 hour incubation, have 
seen that the cells were able to spread and extend on the scaffolds as well as seep through the 
meshes on the scaffolds. 
The use of polymer fibers, such as polyesters, as scaffolds has been tested and has given 
promising results for tissue regeneration. [12-14] Li et al [14] demonstrated that BALB/c C7 
mouse fibroblasts adhered and spread on the surface of the PLGA fiber network while cells grew 
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in the direction of fiber orientation. This favorable cell–scaffold interaction supports the 
biocompatibility of the structure. Ishuag et al [13] have investigated the use of 3-D poly (DL-
lactic-co-glycolic acid) foam scaffolds for transplanting autogenous osteoblasts to regenerate 
bone tissue. The authors reported that the scaffolds supported the proliferation and differentiation 
of cells.  
Among polyesters, poly L-lactic acid (PLLA) seems to be an ideal FDA-approved 
biomaterial due to its non-toxicity and resemblance to the extra-cellular matrix in the brain, thus 
its potential in neural cell regeneration. [15, 16] An image of glial cells and extra-cellular matrix 
is shown in Appendix C (Figure C5). PLLA is biodegradable; PLLA is naturally degraded to L-
lactic acid via hydrolysis of the ester linkages (Figure 1-3). L-lactic acid is eventually 
metabolized in the body to carbon dioxide and water. [17] 
 
Figure 1-3: Hydrolysis of Poly L-Lactic acid to L-Lactic acid 
 
O
O
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Furthermore, growth factor signaling has been shown to have a significant role in tissue 
repair. In the last few decades, our understanding on the role of growth factors on the CNS has 
also greatly increased. [18-20] Furthermore, the inclusion of growth factors within scaffolds 
made of biodegradable and biocompatible polymers is desirable in order to retain them at the site 
of transplantation and control their spatiotemporal delivery to the damaged region of the CNS. 
[21-23] Epidermal growth factor (EGF), a soluble 6kDa polypeptide that is naturally present in 
the CNS, is known to promote the oligomerization and phosphorylation of cell surface EGF 
receptors (EGFRs) leading to cell proliferation and was used in this study. [24-28] Of interest, 
when tethered onto a scaffold, EGF has been shown to promote rapid expansion of neural stem 
cells (NSCs). [24, 29, 30] Amine functionalization on polyethylene terephthalate (PET) with 
ethylenediamine (EtDA) and polyvinylamine (PVam) has been previously reported [31] PLLA 
and PET are two different polymers with different chemical structures as shown in Figure 1-4. In 
this sudy, PLLA nanofibers were found to be very fragile and the necessary adjustments were 
performed and adapted from the above-mentioned protocol. 
 
              PET 
 
PLLA 
Figure 1-4: Chemical structures of Polyethylene terephthalate (PET) and Poly L-Lactic acid 
(PLLA) 
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 The main objective of this work is to fabricate a PLLA scaffold by electrospinning, to 
establish the optimum topological features of nanofibrous mats for neural stem cells and to 
subsequently functionalize it for improved neural stem cell transplantation. More specifically, we 
will investigate EGF grafting onto the PLLA scaffold after surface modification via aminolysis. 
This strategy will combine the advantages of both the PLLA polymer as a cell-scaffold 
(mechanical strength, high porosity, biodegradability and biocompatibility, etc) as well as the 
benefits of tethered EGF. The impact of EGF-grafted PLLA nanofiber scaffolds upon neural 
stem-like cells (NSLC) adhesion, viability and proliferation will be tested. Neural stem-like cells 
(NSLC) were provided by NewWorld Laboratories Inc. They were created from somatic cells 
through reprogramming by NWL. Neural Stem-Like Cells (NSLCs) were engineered from 
human fibroblast cells by transient reprogramming using defined factors. These reprogrammed 
cells are epigenetically stable. They have global gene- and protein-expression profiles that are 
similar to Neural Stem Cells. 
A literature review is presented in the first part of this thesis showing the current 
strategies documented for neural stem cell regeneration.  
Based on the literature review, the second part of the thesis presents, in our opinion, the 
most promising strategy for fabricating and modifying a substrate to promote cell proliferation 
for neural tissue regeneration. An extensive cell culture study was performed on fibers grafted 
with EGF under different media conditions. 
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CHAPITRE 1 GENERAL PROCEDURE 
A literature review summarizing all pertinent work performed in neuronal tissue 
engineering is presented. The literature review consists of the different methods currently 
reported for tissue regeneration. Such strategies include direct injection of stem cells and/or 
growth factors, encapsulated growth factors, hydrogels as scaffolds, etc as well as the surface 
modification of polymeric scaffolds using different bio-macromolecules. The advantages and 
disadvantages of the strategies presented in the literature review are analyzed in an attempt to 
develop an optimized strategy. 
In a second section, an article entitled ‘Fabrication and Surface modification of poly L-
lactic acid (PLLA) scaffolds for growth factor immobilization and neuronal stem cell delivery’ is 
presented. This article was submitted to the Journal of Biomedical Materials Research - Part B, a 
highly interdisciplinary peer-reviewed journal whose common focus is on biomaterials applied to 
the human body and covers all disciplines where medical devices are used. 
The second part of this thesis presents the step- by- step process of the fabrication of 
PLLA electrospun scaffolds, followed with an optimized amine functionalization, and EGF 
grafting. An extensive cell culture study was performed with EGF-grafted fibers under different 
media conditions. Negative controls involving aminated nanofibers and pristine nanofibers were 
performed for comparison, as well as positive control (nanofibers that were only coated with 
laminin). These cell culture assays were used to test for cell adhesion, viability and proliferation 
using our new strategy.    
Finally, future work directions and improvements are proposed such as a grafted-EGF 
density-dependent study, EGF tethering to the PLLA scaffold in an oriented fashion for improved 
bioactivity, and the study of progenitor cell differentiation to specific and appropriate lineages. 
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CHAPITRE 2 LITERATURE REVIEW 
2.1 Direct injection of stem cells for in situ tissue regeneration 
Contrary to what was once believed, studies in the last two decades have shown that the 
CNS does indeed contain neural stem cells and has potential for extensive cellular replacement. 
The discovery of neural stem cells has therefore opened up the development of therapeutic 
strategies for CNS using stem cells. [32] Even though neural stem cells are present in the CNS, 
the quantity of active neural stem cells seems to be very low. Neural stem cells range in size from 
4-50 µm. [33-38] Schematic drawing [39]of NSC and its environment is shown below.  
 
Figure 2-1: Neural stem cell niche with NSC (in blue) [39] 
 
 The injection of additional stem cells at the site of injury for cell regeneration has thus 
been studied. In an animal model where aspects of multiple sclerosis were reflected, adult neural 
stem cell cultured neurospheres were injected in the CNS. The injected cells migrated to the 
damaged areas of the CNS and the animals displayed significant functional recovery. [32, 40] 
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However, the animal experiment may not be translated to humans since multiple sclerosis in the 
human CNS is a chronic and inflammatory disorder that involves both glial and axonal changes 
and its treatment is different from the animal experiment. [32] Another obstacle for the 
implementation of treatments based on direct cell injection is the lack of appropriate factors in the 
host tissue to accommodate the injected stem cells. Altered pathological tissue due to 
Alzheimer’s disease is no longer able to present factors that promote proper differentiation hence 
making it difficult for the injected stem cells to treat the disease. [41, 42] Furthermore, Hansmann 
et al [43] have implanted immortalized oligodendrocyte precursor cells (OPCs) where it has been 
reported that cell injection may result in tumor formation. That is, it has been suggested that a 
failure of molecular control mechanisms in murine glial precursor cell line BO-1 cells, 
responsible for a shift from differentiation to proliferation, led to tumor formation. [43] The 
signal transducer and activator of transcription (STAT)-3 (member of the Janus Kinase 
(Jak)/STAT-pathway downstream of the epidermal growth factor receptor (EGFR)) had been 
used as a tumor suppressor in the PNS but its function in glial tumors is still unknown. [43, 44] 
The presence of CNS stem cells was first discovered when growth factor responsive cells from 
both embryonic and adult CNS stem cells were isolated. [19, 20] Furthermore, studies on stem 
cells have shown that growth factors play a significant role in controlling the fundamental 
process of development. [32] It has been previously reported that direct implantation of human 
mesenchymal stem cells (MSCs) stimulated the synthesis of neuronal survival factors; increased 
endogenous expression of nerve growth factor (NGF), vascular endothelial growth factor 
(VEGF), ciliary neurotrophic factor (CNTF), and basic fibroblast growth factor-2 (FGF-2) as 
well as cell proliferation. [45] These studies showed that the benefits coming from direct stem 
cell injections may be due to their ability to directly produce growth factors and thus provide the 
appropriate cues for proper development/repair. This suggests that the direct injection of growth 
factors may be sufficient instead of stem cell injection. [46] This could explain why, in contrast 
to the CNS that lack Schwann cells, injured peripheral neurons are able to regenerate their axons 
because of their Schwann cells that provide neurotrophic factors. [46] 
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2.2 Direct injection of growth factors for in situ tissue regeneration 
Growth factors are able to maximize the intrinsic regenerative potency of endogenous 
progenitor cells as well as aid exogenous stem cell proliferation and differentiation. [21, 47] It is 
now known that peripheral nerve bridges contain large quantities of NGF, BDNF, neurotrophin-3 
(NT-3), ciliary neurotrophic factor (CNTF) and glial cell-line derived neurotrophic factor 
(GDNF) secreted by Schwann cells, which is the cause of the stimulation of axon growth 
regeneration. [48] Tuszynski et al [49, 50] have genetically modified suspensions of autologous 
fibroblasts to secrete NGF and these modified cells were injected into the central gray matter of 
the non-lesioned thoracic spinal cord. The results demonstrated that axons grew in significantly 
larger numbers when presented with an environment containing growth factors. [49, 50] 
Kobayashi et al [51] have shown that brain-derived neurotrophic factor (BDNF) and 
neurotrophin-4/5 (NT-4/5) prevented atrophy of rat rubrospinal neurons and promoted axonal 
regeneration. Furthermore, Boyd and Gordon [52] have shown that long-term continuous 
treatment with exogenous GDNF significantly increased the number of motoneurons that 
regenerate their axons. However, no significant benefits were observed from the combined 
GDNF and BDNF treatment on the axonal regeneration of motoneurons until after seven days of 
continuous treatment. Vejsada et al [53] have also shown that continuous neurotrophic factor 
delivery was essential in order to promote the long-term survival of axotomized neonatal 
motoneurons. Furthermore, the short half-lives of growth factors, their relatively large size, slow 
tissue penetration and potential toxicity at systematic level exposures limits their use by direct 
injections. [54] A summary of the various growth factors mentioned is presented in Appendix B.  
2.3 Encapsulated Growth factors 
One of the most common approaches used to get controlled drug release is to embed the 
drug into a hydrophilic or hydrophobic matrix; a matrix defined as a three-dimensional network 
containing the drug, polymer, solvents, etc. [55] The drug is then released and the chemical 
kinetics are affected by many factors such as polymer swelling, polymer erosion, drug dissolution 
(re-crystallization), drug diffusion characteristics, particle size distribution, drug-polymer 
interaction, drug distribution inside the matrix, drug/polymer ratio and geometry. [55, 56] 
Biocompatible and biodegradable biomaterials are excellent for the gradual release of a drug or 
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for tissue scaffolds. When designing the biomaterials to be used, many factors are taken into 
consideration such as the degradation rate and the appropriate materials, conditions, dimensions, 
and geometries are chosen for specific applications. [57] Wang et al reported the encapsulation of 
vascular endothelial growth factor (VEGF) and BDNF in PLGA microspheres using the water-in-
oil-in-water emulsion technique. The PLGA microspheres were then embedded within a cross-
linked hyaluronic acid (HA) hydrogel as a delivery system. [58] Although hydrogels are widely 
used for encapsulating growth factors, they release their growth factors in an initial outburst that 
is higher than physiological levels, therefore affecting the duration of the delivery.  [46, 59] Lam 
et al [60] have encapsulated and stabilized NGF into Poly (lactic-co-glycolic) (PLGA) acid 
microspheres by spray-freeze-drying method. First, the human NGF formulations were prepared 
in two different buffer solutions and lyophilized: one buffer system consisting of histidine and the 
other consisting of sodium bicarbonate and zinc acetate. For the spray-freeze drying technique, 
the human NGF formulations were pumped into an ultrasonic spray nozzle with a peristaltic 
pump. The protein was then sprayed into a flask containing liquid nitrogen and merged into a 
liquid nitrogen bath. The frozen protein droplets were poured into a stainless steel tray and dried 
by lyophilization (primary temperature at -25°C for 30 h, followed with secondary drying at 20°C 
for 10 h). The NGF released from the PLGA microspheres degraded at physiological 
temperature. In order to prevent NGF degradation and aggregation during microencapsulation 
and release, PEG or surfactant (pluronic F68) was added to the formulation, however, the 
integrity of the NGF released was not improved.  
2.4 In situ production and delivery of growth factors using cells 
The grafting of primary fibroblasts that are genetically modified ex vivo to produce BDNF 
or NT-3 has been previously reported.[61, 62] However, immune suppression was needed in 
order to prevent the rejection of the grafts. In order to overcome this need for immune 
suppression, previous reports have developed a method based on alginate encapsulation for 
grafting non-autologous BDNF producing fibroblasts into the injured spinal chord.[63] Tobias et 
al [64] have also shown that alginate encapsulation can protect non-autologous BDNF producing 
fibroblasts (Fb/BDNF) from rejection after transplantation into a site of injury and promoted 
behavioral recovery. They have further shown that the grafting of encapsulated Fb/BDNF 
containing cells into a subtotal cervical hemi-section resulted in partial recovery of forelimb 
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usage as well as axonal growth.[64] These cell-containing scaffolds have shown their capability 
to survive transplantation into the injured spinal cord for at least one month in the absence of 
immune suppression.[63] Furthermore, alginate encapsulation was able to protect the Fb/BDNF 
for two months after grafting.[64, 65]   
Layers of cells may be used where the bottom layers are first cultured and can provide the 
requirements needed to the cells of interest (cultured  on top) resulting in the regeneration of 
neuronal structures ex vivo. [46] Zeng et al [66] have cocultured cells from the bone-marrow 
derived stromal cell line PA6 to induce differentiation of human embryonic stem cells (hESCs). 
The production of dopaminergic neurons at a high frequency from hESCs was observed as well 
as the survival of transplanted, tyrosine hydroxylase (TH)-positive cells after 3 weeks of 
differentiation. A bottom layer of PA6 cells was also used as a feeder layer to initiate the neural 
differentiation of BG01 cells. An outgrowth of elongated cells was observed after 6 days in 
culture. However, the survival of dopaminergic neurons after transplantation was limited 
suggesting this method is not ideal. It has also been shown that the co-culturing with PA6 cells is 
simple and fast and can be used with cells from subhuman primates.[67] Other studies reported 
the administration of NGF to the brain using ex vivo gene delivery. [68-72] Genetically modified 
autologous fibroblasts were used to produce and secrete NGF. This method of delivery sustained 
NGF production for at least 18 months, prevented cholinergic degeneration, stimulated 
cholinergic function, and improved memory.[68-72] Tuszynski et al have also applied this 
procedure to humans where genetically modified NGF-producing fibroblasts were injected into 
the brains of 8 subjects suffering from early-stage probable Alzheimer disease.[73] Evidence 
showed that growth factor delivery in this approach has the potential to modify neurological 
disease progression.  
2.5 Scaffolds for stem cell therapy 
In the case of neurodegenerative diseases, the injected stem cells cannot properly 
differentiate because the pathological tissue does not contain the necessary factors.[46] NSC 
transplantation may not be effective because the amyloid precursor protein (APP) metabolism is 
altered and might lead to excessive gliogenesis. Stem cell therapy is challenging due to the blood-
brain barrier that makes it difficult for the neurotrophic factors to diffuse. Also, other causes that 
may explain why the NSCs are not able to regenerate properly in the damaged brain are hostility 
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of the environment; inflammation, glial scar formation, release of inhibitory molecules, and the 
absence of growth-guiding astrocytes. [74] As a result, and because of the fragility of the cells, a 
biomaterial to be used as a scaffold to transplant the stem cells into the host target area appears to 
be highly desirable. Figure 2-2 shows a schematic of a classic tissue engineering process in which 
cells can be isolated from the patient (from a biopsy) and expanded.[75] Two distinct strategies 
are described where one corresponds to the direct injection of cells whereas the other is the use of 
a polymer scaffold. Hydrogels can also be directly injected, in combination with cells, into the 
host environment.[75]     
 
Figure 2-2: Schematic illustration of typical tissue engineering approaches. Cells are obtained 
from a small biopsy from a patient, expanded in vitro, and transplanted into the patient either by 
injection using a needle or other minimally invasive delivery approach, or by implantation at the 
site following an incision (cut) by the surgeon to allow placememnt. [75] 
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2.5.1 Hydrogel as a scaffold 
Hydrogels have shown promising characteristics as they are relatively easy to create, have 
a 3D structure, and the best material can be chosen based on the desired mechanical structures as 
shown in Figure 2-3. [76]  
 
 
Figure 2-3: Hydrogel fabrication and application. [76] 
  
 Numerous studies have been performed on the use of hydrogels as a cell scaffold.  
Hyaluronic acid (HA) hydrogels modified with laminin, harboring similar mechanical and 
rheological properties as brain tissue were shown to inhibit glial formation and support 
angiogenesis. [77, 78] Wei et al have [79] demonstrated that when hyaluronic acid (HA)-based 
hydrogels modified with poly-L-lysine (PLL) and a nogo-66 receptor- antibody (antiNgR) fusion 
protein  (the whole structure being referred to HA-PLL/antiNgR) was administered to rats, 
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inhibition of glial scar formation was observed. HA, however, is highly hydrophilic; in order to 
undergo cell proliferation, cells need a substrate that is neither too hydrophilic nor too 
hydrophobic. [80] Woerly et al [81] have evaluated the application of Poly[N-(2-hydroxypropyl) 
methacrylamide] (PHPMA) hydrogels for the promotion of axonal regeneration in the transected 
rat spinal cord. Following implantation, the hydrogel was able to bridge tissue defects, favored 
cell ingrowth, angiogenesis and promoted axonal growth. Their similarity in viscoelastic 
properties to neural tissue (as well as large surface area) contributes to their success as a strategy 
for neural tissue regeneration. Type I collagen has been used as an injectable hydrogel while 
inhibiting glial scar formation after spinal cord injury. [82] However, telopeptide regions are 
present during gel formation for crosslinks between molecules. These telopeptide regions are 
implicated in antigenicity and render the gels weaker when removed. [83] 
 Furthermore, some limitations of hydrogels as potential scaffold for neural tissue 
engineering include their high cost and low mechanical strength. [75, 84] 
2.5.2 Electrospun Fibers 
A variety of methods exist for the fabrication of PLLA nanofibers; they can be fabricated 
by liquid-liquid phase separation, [85] or thermally induced phase separation method [86], as 
well as melt spinning method (melt extrusion and hot draw). [87] Recently, electrospun scaffolds 
have been assayed as a substrate to support cell regeneration. [10, 16, 88, 89] Electrospun fibers 
have been fabricated for the generation of scaffolds destined to neural tissue engineering because 
of their interconnected pores, high porosity, high surface area-to-volume ratio, and topography 
that mimic the natural extracellular matrix (ECM). Electrospun fibers have been demonstrated to 
support the attachment and differentiation of various neuronal cells, such as dorsal root ganglion 
neurons (DRG), Schwann cells, hippocampal neurons, as well as PC12 cells. [90]  
2.6 Electrospinning  
Electrospinning is a fabrication technique that produces polymeric fibers using 
electrostatic force. It is possible to obtain fibers from a wide variety of materials such as poly (e-
caprolactone) (PCL), poly lactic-co-glycolic acid (PLGA), poly lactic acid (PLA), etc. Fiber 
properties such as diameter, porosity, and alignment can also be tuned during the electrospinning 
process. This technique consists of placing a polymer solution in a syringe where a strong 
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difference of potential is applied between a metallic collector and the metallic needle. A droplet 
charged with static electricity in the shape of a Taylor cone is then created. This droplet is 
attracted by the electric field in the direction of the collector where charge repulsion exceeds the 
surface tension, [91] and evaporates during its flight, creating fibers with a diameter varying from 
tens of nanometers to a few micrometers. [92] Electrospun fibers are attractive for scaffold 
production due to the relative simplicity of its fabrication, (summarized in Figure 2-4), its 
tunability and its cost-effectiveness. 
 
Figure 2-4: Electrospinning set-up. [93] 
2.6.1 Polymer solution conditions 
A suitable solvent that is able to dissolve the polymer while possessing suitable vapor 
pressure is usually chosen. A good solvent is one that evaporates quickly enough for the fiber to 
maintain its integrity when it reaches its target but not too quickly in order to allow the fiber to 
harden before reaching the collector. Furthermore, the quality of the solvent [94], as well as the 
temperature of the solution has an effect on fiber diameter. [95] There are also many other 
conditions that can influence the nanofiber topography and morphology (e.g., beaded, random, or 
aligned, etc) such as polymer concentration, molecular weight, solution viscosity, surface tension, 
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solution conductivity, dielectric effect of solvent, voltage, feed rate, collector speed, distance 
between tip and collector, ambient temperature and humidity. 
2.6.1.1 Polymer concentration, molecular weight, and solution viscosity 
Polymer concentration has an effect on fiber diameter as well as fiber morphology. 
Generally, higher polymer concentrations yield nanofibers of larger average diameters. [96] 
Another factor affecting the viscosity of the solution is the molecular weight (Mw) of the 
polymer. The molecular weight represents the length of the polymer chain and determines the 
amount of polymer entanglements in a solution. Low Mw polymer solutions are not able to form 
fibers when electrospun. [93] Furthermore, Mw directly affects the viscosity, which is 
understandable since the amount of polymer chain entanglements in the solvent are determined 
by polymer length. Usually, a low viscosity solution tends to result in bead formation in the fiber 
structure. [93, 97] Also, when the viscosity of the solution is low, there may be a secondary jet 
that erupts from the main jet and cause a variety of different fiber diameters. [93, 98] When too 
viscous, solutions can also dry at the tip of the needle, preventing electrospinning. [10, 99] 
Additionally, at very low humidity, the solvent evaporation rate is higher causing clogging to 
occur at the needle tip. [93] 
2.6.1.2 Surface tension 
The surface tension is defined by the tractional force, γ, acting across any unit length of 
line on the interfacial membrane (i.e. liquid and vapour). [100] To begin the electrospinning 
process, the charged solution must first overcome its surface tension, allowing the stretching of 
the polymer solution to reach the collector without the formation of beads. [93] The Coulomb 
repulsion between the charged ions in a polymer solution favors the creation of a jet, whereas the 
surface tension of the solution favours a sphere-like shape. When the electrical potential of the 
surface is increased, the electrical forces dominate the surface tension of the solution and a 
charged jet of fluid (referred to as the Taylor cone) is released as shown in Figure 2-5 where the 
Taylor cone is shown at the top of the illustrations. [101] 
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Figure 2-5: Taylor cone shown at top of images. Lower voltages result in thinner fluid jets as well 
as less fluid being drawn from syringe where the interference colors provide information on jet 
diameter. [102] 
2.6.1.3 Solution conductivity 
The conductivity of a solution is a measure of its ability to conduct electricity. The 
presence of ions has an effect on the conductivity; many of the solvents used in electrospinning 
possess a certain level of conductivity. The stretching of the polymer solution from the syringe is 
caused by the repulsion of the charges at the polymer surface. An increase in the stretching of a 
solution results from the increase of charges, leading to bead-less fibers. An increase in polymer 
solution stretching also results in fibers with smaller diameters. [93, 99] 
2.6.1.4 Dielectric effect of solvent 
The dielectric constant (a quantity measuring the ability of a substance to store electrical 
energy in an electric field) of a solution plays a major role in electrospinning. A solvent with a 
high dielectric constant will result in a fiber with smaller diameters and less beads. [93] 
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2.6.2 Electrospinning process conditions 
External factors such as voltage, feed rate, temperature of  solution, ambient temperature, 
humidity, type of collector, diameter of needle, and distance between tip and collector also play a 
role in the outcome of fiber morphology. 
2.6.2.1 Voltage 
Taylor cones define the onset of extensional velocity gradients in the process of forming 
fibers. [103] The polymer jet exits the syringe needle and forms a Taylor cone when a high 
voltage is applied and the electrostatic force overcomes the surface tension of the solution; the 
coulombic repulsive force in the jet then stretches the solution. Generally, a high voltage leads to 
smaller fiber diameters; this is due to the fact that a higher voltage will lead to an increase in  
stretching of the solution. Lower voltages result in thinner fluid jets and less fluid is drawn from 
the syringe as shown in Figure 2-5 where the interference colors provide information on jet 
diameter. [101] 
A higher voltage can cause instability of the jet and Taylor cone, causing them to recede 
into the syringe needle, resulting in beaded fibers. [93]  
2.6.2.2 Feed rate 
The feed rate cannot be too high in order to give enough time for the solvent to evaporate 
during flight. When the feed rate is increased, the fiber diameter or bead size is also increased. 
[93]  
2.6.2.3 Effect of collector 
The collector plate is usually made out of a conductive material such as aluminum foil 
and/or a metal plate, which is electrically grounded. Once the voltage is turned on, there is an 
electric field between the source and the collector, hence attracting the polymer solution towards 
the collector. [93] 
2.6.2.4 Distance between tip and collector 
The distance between tip and collector has an effect on resulting fibers. For example, 
beads can be observed when the distance is too low. [104] This is due to the fact that decreased 
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distance causes an increase in field strength. A distance that is too high may either decrease or 
increase the fiber diameter [93] therefore an optimal distance is necessary in order to achieve the 
desired fiber morphology. 
2.6.2.5 Ambient humidity and temperature 
Water condensation can form on fibers when the humidity is too high and this can affect 
the fiber morphology. [93, 104] The humidity can affect the diameter and porosity of the fibers. 
[105, 106] The humidity and temperature have a significant effect on average fiber diameter. At 
high ambient humidity (higher than the optimal range of 20-40 % relative humidity), the fiber 
diameter of a polymer can decrease and form beads as represented in Appendix C (Figure C3), 
which can pose a potential challenge. [107] Furthermore, the solution absorbs ambient water at 
high humidity leading to the fusion of fibers at the collector [107] as demonstrated in Appendix C 
(Figure C4). 
2.7 Tissue engineering 
Tissue engineering is the application of the principles of engineering as well as life 
sciences to make a biological substitute, which often contains cells and biodegradable scaffolds 
co-cultured in vitro, that can restore, maintain or improve tissue function. In tissue engineering 
procedures, artificial extracellular matrices (ECM), i.e. biomaterials, are often used as scaffolds 
for cells to grow in. Cells interact with the biomaterials where their initial interaction is 
determined by the chemical composition, surface energy, roughness, and surface topography that 
are in direct contact with cells.[108] Cell adhesion, migration, differentiation and proliferation 
depend on biological cues such as growth factors and cytokines; they also depend on chemical 
and physical characteristics of the biomaterial surface.[108] Polyesters such as poly lactic acid 
(PLA) are FDA-approved; they are biodegradable, biocompatible, and non-toxic. Polyester 
surfaces have poor hydrophilicity, however, and lack functional groups that may ease chemical 
tailoring of their surface. Hence, the introduction of such functional groups is usually needed. 
Many different surface modification methods have been reported such as plasma treatment[109, 
110], surface hydrolysis[111], chemical grafting[112], physical adsorption[113] and self-
assembly technology.[114]  
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2.7.1 Biological response to biomaterials 
In order to develop an efficient biomaterial, the understanding of cell interactions with the 
extracellular matrix (ECM) is important. In a normal biological situation, cell-cell interactions are 
mediated and modulated by signaling complexes that occur through adhesion receptors on cell 
surfaces when cells interact with the ECM. Cells adhere to their ECM through their cytoskeleton 
actin filaments. Cell membrane receptors, called integrins, are what mediate this adhesion. [108] 
The ECM also acts as a reservoir for growth factors whose diffusion (and thus availability) is 
controlled by the ECM physical properties. The ECM protects the growth factors from 
degradation and regulates their synthesis. [115] 
Once the biomaterials are implanted in the body, the first step that occurs is water 
adsorption, followed by protein adsorption prior to cell attachment. The surface properties of 
biomaterials are important in that they determine the binding strength and structural arrangement 
of water molecules, which may affect later protein-surface, and thus cell-surface interactions. The 
porosity of a biomaterial also has an effect on cell behavior. Gugala et al reported the superiority 
of porous membranes to non-porous ones from poly (L/D-lactide) 80/20% for the growth and 
osteoblastic differentiation of rat bone marrow stromal cells in vitro. [108] 
2.8 Poly lactic acid (PLA) and poly L-lactic acid (PLLA) 
2.8.1 General 
Poly(α-hydroxy acids) such as poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and 
their copolymers have been widely used as biomaterials. [116, 117] PLA is a thermoplastic, high 
strength, high-modulus aliphatic polyester made from renewable resources, more specifically α-
hydroxy acids, which include polyglycolic acid or polymandelic acid. PLA is formed by direct 
condensation polymerization of lactic acid. Similarly, poly L-lactic acid is formed by 
polycondensation of the L enantiomer. The stereochemical structure of poly lactic acid can be 
modified by polymerizing a controlled mixture of the L- or D-isomers in order to yield either 
amorphous or crystalline, high molecular weight polymers. [118] Lactic acid has been first 
isolated in 1780 from sour milk and has many food-related applications. It is used as a buffering 
agent, acidic flavoring agent, acidulant and bacterial inhibitor in many processed foods and can 
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be manufactured by carbohydrate fermentation or chemical synthesis. [118] As mentioned earlier, 
lactic acid (2-hydroxy propionic acid) exists in two optically active configurations; the L(+) 
isomer is produced in humans and other mammals, whereas the D(-)- and L(+)-enantiomers are 
produced in bacterial systems. There are two different routes for PLA polymerization. The first 
route is through polycondensation from lactic acid to yield low molecular weight PLA. The 
second route is from lactide through ring-opening polymerization process to yield poly lactic acid 
as shown in Figure 2-6.   
 
Figure 2-6: Synthesis of PLA [118] 
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2.9 Surface modification 
The chemical structure, hydrophobicity, ionic groups, morphology, and topography of the 
biomaterial have an effect on the interaction with surrounding biological environment. 
Furthermore, the surface properties such as wettability, surface charge and topography affect cell 
adhesion. [108] Additional factors that influence the cell interactions with the scaffold include the 
structure of the biomaterial, porosity, pore size, geometry, distribution, surface texture such as 
roughness, pattern, orientation, and surface chemical properties such as free energy and surface 
micro-morphology. The porosity of a scaffold plays an important role in directing tissue 
formation and function. [119, 120] A high porosity (higher than 80%) [85] is necessary in a 
scaffold for homogeneous cell distribution and interconnection as well as diffusion of nutrients 
and oxygen. [121] The stiffness of a material also decreases as the porosity is increased. [121] 
Pore size also has an impact on the amount of contraction a scaffold will undergo after 
implantation. [121] For example, a pore diameter ranging from 20–125 µm was needed for 
contraction-inhibiting activity to be observed in collagen–glycosaminoglycan graft copolymers 
used for dermal repair. [122] Choice of pore size is also related to the cell type to be cultured. 
[121] Furthermore, the maximum fiber thickness recommended for tissue engineering scaffolds is 
150-200 µm due to the inability of and insufficient oxygen and nutrient transport within the 
deeper compartments of the biomaterial. [121, 123] 
Surface modifications of biomaterials in an alkaline solution could be used for the 
production of hydrophilic and rough surfaces. [108] Cell adhesion to ECM proteins is mediated 
by integrins where they organize into complexes that contain structural and signaling proteins. 
There has been a large development to the modification of polyester surfaces. Several methods of 
surface modification are possible such as chemical grafting, surface coating, entrapment, and 
electrostatic self-assembly.  
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2.9.1 Aminolysis 
Aminolysis can be used prior to the grafting of bioactive molecules where primary amines 
are introduced by thermally induced aminolysis. The aminolysis reaction is based on the 
nucleophilic attack of an amine onto the ester bonds of a polymer chain via polymer-chain 
scission and has been widely used in literature for the addition of amine groups. Fadeev et al have 
added amine groups on PET surfaces using polyamines. [124] Furthermore, Yang et al [125] 
reported UV-light-induced surface aminolysis reactions. The tertiary amines are functionalized 
onto the PET surface, are easily protonated and used for electrostatic immobilization of proteins. 
Studies have also reported the addition of amine groups using a small diamine, ethylenediamine 
(EtDA)[31, 126] as well as an aminated polymer, polyvinylamine (PVam). [31, 127] The 
aminated PET films were followed with the functionalization of Succinimidyl 6-[3-(2-
pyridyldithio)-propionamido]hexanoate, LC-SPDP linker, an amino-reactive molecule. The LC-
SPDP functionalization of substrates could be followed with the oriented immobilization of 
cysteine-tagged proteins. [128, 129] 
2.9.2 Surface coating/physical adsorption of proteins 
Most materials need to be coated in order to improve cell adhesion, even electrospun 
fibers. [37, 130] This is due to the poor hydrophilicity of polyester surfaces. [108] Biomaterials 
as scaffolds are limited by the ability of attached cells to dynamically repopulate. [131, 132] 
Surface coating with, for example, collagen and laminin provide an adhesive interface between 
biomaterial surfaces and cells. Garic et al modified PLA surfaces by creating tiny cavities by 
sodium hydroxide, as well as coating with type-I collagen for comparison. [133] Results showed 
that human keratinocytes preferred growing on partially hydrolyzed surfaces. This study has 
suggested that other surface modifications can further improve keratinocyte culture on PLA. 
However, it has been reported that surface coating of proteins via adsorption may affect the 
topography of the scaffold and thus cell fate. [16] For this reason, other methods of incorporating 
proteins and growth factors have been explored.  
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2.9.3 Chemical grafting of proteins 
Soluble growth factors have been used to help regeneration after spinal chord injury using 
mini pump technology. [134] This method has shown the importance of a stable gradient for 
guidance; it has also shown a limitation where the soluble growth factors need to be constantly 
replenished. Protein grafting was therefore attempted in vivo. Since surface immobilized growth 
factors are biomimetic [135-139], it has been hypothesized that they can guide neurites similarly 
to soluble growth factors. [134] Kapur et al [134] have photochemically bound nerve growth 
factors (NGF) via photoreactive PAAm onto microporous poly(2-hydroxyethylmethacrylate) 
(PHEMA) gels. Results showed that 30 ± 7% of the pheochromocytoma (PC-12) cell population 
responded to bound NGF, similarly in comparison to cells cultured on collagen in the presence of 
40 ng/ml soluble NGF (39 ± 12%). Zhu et al showed a method for the photochemical 
immobilization of gelatin and chitosan onto polyesters. [140] Results showed that fibroblast cells 
did not spread on the chitosan-PLGA or pure PLGA surface after 2h but spread on the gelatin-
chitosan-PLGA surface.  
2.9.4 Proteins for surface modification 
2.9.4.1 Collagen 
Collagen adsorption 
 Some natural materials such as collagen, fibronectin, and some peptides have been 
reported as scaffold modifiers. [134] Tjia have shown the benefits of adsorbed collagen onto a 
scaffold. [141] They have reported that, in the absence of any treatment, keratinocyte migration 
on PLGA substrates was poor. However, substrate conditioning with type I collagen can enhance 
the rate of migration significantly. Furthermore, the combined presence of substrate-adsorbed 
collagen in conjunction with a cell-derived protein (fibronectin) can activate keratinocyte 
migration onto PLGA substrates. [141] Additionally, He et al [142] have coated collagen on 
electrospun nanofibers and reported an enhanced spreading, attachment, and viability for human 
coronary artery endothelial cells.  
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Collagen grafting 
Li et al have used electrospun nanofibers on which collagen had been immobilized for 
neural stem cell culture. [143] Collagen was grafted onto a copolymer of methyl methacrylate 
(MMA) and acrylic acid (AA) nanofiber surface via EDC/NHS activation. It was reported that 
the cell viability and cell proliferation were improved on the collagen-modified surfaces when 
compared to that on the unmodified surfaces. Ito et al [144] have immobilized collagen onto 
poly(methyl methacrylate) (PMMA) films, which has resulted in the flattening of cells during 
early cell adhesion but did not enhance cell growth significantly. [145]  
2.9.4.2 Laminin  
Laminin adsorption 
Laminin plays an important role in cell migration, differentiation, and axonal growth. 
[146] It is one of the proteins present in the ECM and is continuously synthesized after nerve 
injury in the PNS. [147] Also, myelination in the PNS is not observed in the absence of laminin. 
[148, 149]  Laminin adsorption onto scaffolds has been shown to promote neurite outgrowth 
through directional guidance. [150, 151]  
Laminin grafting 
Koh et al [152] have compared the addition of laminin to nanofibers using covalent 
binding, physical adsorption, and blended electrospinning. In general, they have shown that 
laminin modified nanofibers supported cell adhesion, cell viability and proliferation as well as 
neurite outgrowth when nerve growth factors were introduced. More laminin were found in the 
blended laminin-PLLA nanofibers than immobilized laminin and physically adsorbed laminin. 
This could be the reason why more neurite outgrowth of PC12 cells was observed on blended 
laminin-PLLA than on the other modified nanofibers. However, this technique was not efficient 
at achieving high cell viability. Laminin has a higher tendency to promote neurite outgrowth than 
to enhance the viability of nerve cells. [152, 153] Another drawback is that the approach 
undertaken in this study still required the use of nerve growth factors (NGF) in the medium. 
Some studies have shown that NGF plays a role in the maintenance of central neurons and in the 
control of laminin production. [153, 154] 
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2.9.4.3 EGF 
EGF adsorption 
EGF is known to be a functional target for the clinical treatment of damaged tissues. [155] 
As previously discussed, EGF plays an important role in cell proliferation, differentiation and 
migration, thus aiding in wound healing and tissue regeneration. Non-specific adsorption of the 
epidermal growth factor (EGF) onto a substrate has been shown to dramatically decrease its 
bioactivity. [156] This is most likely due to the inappropriate orientation of EGF or possible 
adsorption-induced conformational changes of EGF. [156] Some reports have also shown that 
physically adsorbed EGF on insoluble glass substrates showed no activity. [157] This could mean 
that receptor motility is important in the signaling for both the mitogenic and morphologic 
response or that the conformation of physically adsorbed EGF is unsuitable for stimulating the 
EGFR. [157] These results showed that the mere presence of EGF on the surface is insufficient to 
trigger a biological response. [157] 
2.9.4.4 EGF grafting 
When soluble EGF is used, it is difficult to control its local concentrations due to cellular 
uptake and diffusion. [158] For the cells to properly respond to growth factors, the time-span of 
their presence in the desired target tissues is important. [159] When a controlled release system is 
used, maintaining a signal at the cell surface is difficult due to endocytosis of growth factor-
receptor complexes. [158] Therefore, new strategies are needed to overcome these obstacles. This 
is where the immobilization of growth factors comes into play; covalent immobilization of EGF 
onto a scaffold is non-endocytosible and non-diffusible, allowing cell surface events involving 
signal transduction to occur. Furthermore, immobilization can be used in order to spatially 
control EGF densities or concentrations.[158] To further support the use of tethered EGF, it has 
been reported that adsorbed EGF shows very low, if not non-existent biological activity. [157, 
160] Furthermore, surface coating of proteins via adsorption may affect the topography of the 
scaffold and thus cell fate. [16] Grafting of proteins enable long-term delivery, allows proteins to 
remain stable and functional for several months, and have shown positive results in activating 
intracellular signaling pathways thus influencing cell fate. [161] Therefore, the purpose of this 
study is to optimize current neural tissue regeneration strategies by immobilizing EGF onto a 
PLLA scaffold. 
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2.10 Mechanical properties 
Studies have shown that mechanical properties of the brain tissue affect neural stem cell 
behavior.[8, 162] Cells respond not only to biological and chemical properties but to the physical 
properties of the extracellular matrix, [163, 164] such as the stiffness of substrates. The stiffness 
of a substrate has an effect on cellular behavior in a cell-type specific manner.[165, 166] Mouse 
spinal cord neurons have less dendritic branches on stiffer bis-acrylamide cross-linked hydrogels 
(E ~ 1500 Pa) than on softer gels (E ~ 150 Pa) while glial cells do not grow on these gels at 
all.[166] The focal adhesions and motility of cells are affected by the substrate flexibility.[167] It 
is thus ideal for a substrate to have similar mechanical properties to its host tissue. Neural cells do 
not survive well in a biomaterial that is either too soft or too stiff. However, those that do survive 
at the lower stiffness tend towards a neuronal cell fate, whereas astrocytes develop more 
predominantly on stiffer materials. The young modulus of both white and grey matter of the 
human brain was reported to be 0.00015MPa-0.01MPa [168, 169] 
2.11 Problem identification 
Recent tissue engineering strategies exist that rely on the inclusion of growth factors (or 
other proteins) within appropriate structures made of biodegradable and biocompatible polymeric 
materials. However, current existing strategies have some limitations such as their use of 
scaffolds (i.e. PMMA) that are not biodegradable [144, 145] with collagen immobilization that 
did not enhance cell growth significantly. [144] Furthermore, current strategies using 
immobilized laminin did not enhance cell viability and still required the use of NGF in the 
medium (in addition to the immobilized laminin) to help promote cell proliferation and 
differentiation. [153] This study will optimize current existing tissue engineering strategies by 
immobilizing EGF (via aminolysis) that has been shown to promote cell proliferation, 
differentiation, etc onto the biodegradable, biocompatible electrospun PLLA that mimics the 
ECM.  
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2.12 General Objective 
The general objective of this study is to establish the optimum topological features of 
nanofibrous mats for neuronal stem cells, to evaluate the effect of adding chemical functionalities 
via a surface modification strategy for the attachment of epidermal growth factors as well as 
study its impact on cell adhesion, proliferation, and viability. 
2.12.1 Specific Objectives 
In order to develop answers to the questions of the general objective, several specific 
objectives are defined: 
The first specific objective is the development and amine functionalization of poly lactic 
acid (PLLA) nanofibers (with the desired characteristics such as average fiber diameter, fiber 
thickness, etc). 
The second specific objective is the covalent immobilization of epidermal growth factors 
onto the modified structures in order to study the impact of the epidermal growth factor 
immobilization on biomaterial scaffolds by observing cell adhesion, proliferation and viability 
via cell culture assays.  
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CHAPITRE 3 FABRICATION AND SURFACE MODIFICATION OF 
NANOFIBERS 
3.1 Presentation 
 Based on the literature review, electrospun PLLA biomaterials are the most ideal for our 
strategy. PLLA fibers with a selected diameter and with a high porosity were obtained. The 
specific topology (fibers diameter and alignment) were optimized (results summarized in the 
appendix) and used for the subsequent steps of the work. Surface modification of the electrospun 
PLLA via aminolysis and EGF grafting rendered the substrate more suitable for cell proliferation 
and spreading. These results were submitted in the Journal of Biomedical Materials Research - 
Part B and are presented below. 
 
3.2 Article 1: Fabrication and Surface modification of poly L-lactic 
acid (PLLA) scaffolds for growth factor immobilization and 
neuronal stem cell delivery1. 
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ABSTRACT 
 Poly L-lactic acid (PLLA) is a polymer commonly used in neural tissue engineering. In 
this study, PLLA-based electrospun fibers destined to nervous system repair strategies were 
optimized by covalently grafting epidermal growth factor (EGF). Electrospun PLLA nanofibers 
were first functionalized with polyallylamine to introduce amine groups before EGF grafting via 
a bis-N-succinimidyl-pentaethylene glycol ester (PEG) linker. Engineered neural stem-like cells 
(NSLC) were then seeded onto the modified substrates and were shown to be viable up to 14 
days, while proliferating and spreading. 
 
 
 
KEYWORDS 
 
Poly L-lactic acid, epidermal growth factor grafting, amine functionalization, cell proliferation, 
adhesion
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3.2.1 Introduction 
With 12,000 new cases occurring every year and over one million North Americans 
suffering from paralysis caused by spinal cord injury (SCI), SCI is a devastating condition for 
which no effective treatment exists. [170] Similarly, strokes, cancer, trauma and degenerative 
diseases affecting the brain (e.g. Parkinson’s (PD) and Alzheimer’s diseases (AD)) are also some 
of the many sources of damage of the central nervous system (CNS). They are costly to society 
and are the leading causes of death and injuries in North America. [1]  
Intrinsic repair of the CNS is very limited, possibly due to some inhibitory factors present 
at the injury site associated with nearby glia, preventing functional regeneration. [4, 21] Of 
salient interest, recent progress within the field of stem cell therapy has provided researchers with 
promising repair strategies for CNS. The use of human neural stem/progenitor cells (NSPC) has 
attracted a lot of interest since these cells can be expanded easily, and since their neural lineage is 
inherently specified. They have given extremely promising results in animal models.[171-173]  
Among the various strategies reported, the use of NSPC first requires their selective 
expansion, a process that involves the use of specific growth factors (i.e., the epidermal and 
fibroblast growth factors, EGF and FGF, respectively).[24, 174] 
 In many studies, the implantation of NSPC has also been accompanied with concomitant 
infusion of growth factors to promote cell survival, proliferation and differentiation. For example, 
mouse brain-derived NSPC differentiation into oligodendrocyte was promoted by the mixing of 
epidermal, fibroblast and platelet-derived growth factors (EGF, FGF and PDGF), ultimately 
resulting in improved locomotor function.[175, 176] Recently, the combination of these growth 
factors to a soluble dimeric version of the Nogo-66 receptor (to block the inhibitory effect of 
myelin-based inhibitors) was reported to increase survival of NSPC and augment axonal 
regeneration.[22] To retain growth factors (and other proteins) at the site of transplantation, the 
most recent experimental strategies rely on their inclusion within appropriate structures made of 
biodegradable and biocompatible polymeric materials. [21-23] This controls their spatiotemporal 
delivery to damaged regions of the CNS, while providing a scaffold to guide regeneration. For 
that purpose, electrospun poly(L-lactic acid) (PLLA) nanofibers have been studied for cell 
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differentiation and neurite outgrowth.[16, 88] Electrospun scaffolds are highly porous and their 
topography mimics the natural extracellular matrix (ECM), which make them good candidates for 
neural tissue engineering.[10, 89] Furthermore, PLLA is FDA-approved, biocompatible and 
biodegradable, making it a relevant polymer for these types of scaffolds.[16, 177] However, 
polyester surfaces are characterized by a suboptimal hydrophilicity for cell adhesion, which may 
limit their use unless functional groups or molecules promoting cell attachment are introduced.   
To improve cell adhesion and proliferation onto electrospun PLLA, previous studies reported the 
use of either laminin [152, 178] or other proteins, as they were shown to improve cell 
adhesion.[37, 130] The coating of adhesive molecules, however, is known to affect the surface 
topography of scaffolds.[16] To reduce this side effect, the incorporation of biomolecules onto 
the substrate via blends, electrospinning, co-electrospinning or subsequent covalent binding has 
been proposed.[108, 144, 152, 179-181] Surface modification such as the aminolysis technique 
has been widely studied in literature [124, 125]; the aminolysis reaction is based on the 
nucleophilic attack of an amine onto the ester bonds of a polymer chain via polymer-chain 
scission and is used for the addition of amine groups in order to covalently bind bioactive 
molecules. Studies have also reported the addition of amine groups using a small diamine, 
ethylenediamine (EtDA) [31, 126] as well as an aminated polymer, polyvinylamine 
(PVam).[127] The aminated PET films were followed with the functionalization of Succinimidyl 
6-[3-(2-pyridyldithio)-propionamido]hexanoate, LC-SPDP linker, an amino-reactive molecule. 
The LC-SPDP functionalization of substrates could be followed with the oriented immobilization 
of cysteine-tagged proteins.[128, 129] 
In this study, PLLA nanofibers were fabricated by electrospinning to be used as neural 
tissue engineering scaffolds. The PLLA scaffolds were functionalized with amine groups via a 
novel aminolysis treatment using polyallylamine (PAAm). The prepared scaffolds were 
characterized by scanning electron microscopy (SEM) and amine moieties were quantified using 
the Orange II method.[182] Epidermal growth factor (EGF) was then tethered onto the PLLA 
electrospun scaffolds. EGF has been chosen because it is naturally present in the CNS and is 
known to promote the oligomerization and phosphorylation of cell surface EGF receptors 
(EGFRs) leading to cell proliferation.[24, 26-28, 174] The impact of our EGF-grafted PLLA 
nanofiber scaffolds upon neural stem like cells (NSLC) adhesion, survival and proliferation was 
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then evaluated, with the ultimate goal of developing an improved strategy for central nervous 
system repair. 
3.2.2 Materials and methods 
3.2.2.1 Materials 
Commercial poly L-lactic acid (PLLA) pellets (Cat. # 4032D; 30% crystalline, L-content 
= 98%) were purchased from NatureWorks LLC (Blair, NE). Milli-Q quality water (18.2 MΩ 
cm; total organic compounds (TOC) = 4 ppb was produced from a Millipore Gradient A 10 
purification system. Sodium hydroxide (NaOH, 99.3% purity), ethanol (EtOH, 99.9% purity), 
methanol (MeOH, 99.9% purity), dioxane (99+% purity), and hydrochloric acid (HCl, 37.7% v/v) 
were obtained from VWR International, Ltd. (Mont-Royal, QC). Orange II sodium salt (98% 
purity) and potassium chloride (KCl, 99+% purity) were obtained from Sigma-Aldrich Canada, 
Ltd. (Oakville, ON). Ethylenediamine (EtDA, 99+% purity) was obtained from Fisher Scientific, 
Ltd. (Nepean, ON). The linear aminated polymer polyvinylamine (PVAm) and polyallylamine 
(PAAm) were obtained from Polysciences, Inc. (Warrington, PA). Dulbecco’s phosphate 
buffered saline (modified PBS, without calcium chloride and magnesium chloride), Tween 20, 
analytical grade dichloromethane (DCM) and trifluoroacetic acid (TFA) from Sigma-Aldrich 
(Oakville, ON) were used as received. Bis-N-succinimidyl-(pentaethylene glycol) ester 
(Bis(NHS)PEG5) was purchased from Pierce Biotechnology (Rockford, IL). Streptavidin HRP 
enzyme (part # 890803), Substrate reagent pack (Cat. # DY999) containing Peroxide A (part # 
895000) and Chromagen B (part # 895001) and the reagent diluent Bovine Serum Albumin (Cat. 
# DY995) were purchased from R&D systems (Minneapolis, MN, U.S.A). Ethanolamine (99+% 
purity) from Sigma-Aldrich (Oakville, ON) was used. Recombinant human epidermal growth 
factor (rhEGF, 97+% purity, Cat. # 236-EG) was from R&D systems (Minneapolis, MN, U.S.A).  
3.2.2.2 Preparation of random PLLA nanofibers using electrospinning 
The polymer solutions for the fabrication of the nanofibers were prepared by dissolving 
PLLA (2 g) into a mixture of DCM (7 mL) and TFA (6 mL) to yield a PLLA concentration of 
15.4% w/v. The polymer solution was placed into a glass syringe (Cadence scientific, Staunton, 
VA; needle size 22 G) and the injection was controlled by a syringe pump (KDS100, KD 
Scientific Inc., Hollistin, MA) at a feeding rate of 0.5 mL h-1. A rotating collector was used for 
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random nanofiber fabrication at a rotation speed of 175 rpm. A voltage of 23.75 kV was applied 
by a voltage regulated DC power supply (ES30P/0.2/230/M826, Gamma High Voltage Research, 
Ormond Beach, FL). The PLLA nanofibers were collected on non-stick aluminum foil at a 
distance of 10 cm from the needle. 
3.2.2.3 Nanofiber amination and amine group quantification 
Glassware was carefully cleansed by overnight immersion in a bath of KOH-saturated 
isopropyl alcohol, followed by intensive rinsing with Milli-Q water. The PLLA nanofibers were 
rinsed extensively in ethanol and dried in a laminar flow cabinet at room temperature (RT). 
Before immobilization of EGF on nanofibers, an aminolysis step was performed using three 
different procedures. After aminolysis, the PLLA nanofibers were extensively rinsed in ethanol 
and Milli-Q water and dried in a laminar flow cabinet at room temperature. 
3.2.2.4 Polyallylamine (PAAm) functionalization      
An alkaline solution of NaOH and KCl (1:1, 150 mM in Milli-Q water) as well as a 
solution of PAAm•HCl (85.5 g L-1 in Milli-Q water) were prepared. The aforementioned alkaline 
and PAAm solutions were then mixed with dioxane (67:26:7% v/v). Prior to dioxane addition, 
the pH was adjusted to pH 11.5 or 12.5 by adding few microliters of HCl (12.3 M). The solution 
was degassed under vacuum for 20 min while stirring. The PLLA fibers were then immersed in 
the solution and the reaction was carried out for 1 h at 50°C.  
3.2.2.5 Polyvinylamine (PVam) functionalization  
A solution of PVAm•HCl (120 g L-1 in Milli-Q water) was prepared. The PLLA fibers 
were immersed in a degassed mix of the alkaline solution previously described, the PVAm 
solution and dioxane (67:26:7% v/v) for 1 h at 50°C. The pH of the aqueous solution was set to 
pH 12.5 prior to dioxane addition. 
3.2.2.6 Ethylenediamine (EtDA) functionalization 
The PLLA fibers were immersed in a solution of EtDA/MeOH of varying concentrations 
(0.5, 1, 5, 20 and 30% v/v). The reaction was carried out at 50 °C for reaction time set to 10, 20, 
30 and 40 min. 
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3.2.2.7 Amine group quantification   
Following aminolysis, the density of amine groups was evaluated using a colorimetric 
assay (Orange II method).[182] Briefly, the substrates were immersed in 1.5 mL of dye solution 
(14 mg mL-1) in acidic solution (Milli-Q water adjusted at pH 3 with 1 M HCl solution) for 30 
min at 40°C. The samples were intensively rinsed 3 times using the acidic solution (pH 3) to 
remove unbound dye. The colored substrates were immersed in 1 mL of alkaline solution (Milli-
Q water adjusted to pH 12 with a 1 M NaOH solution) once air-dried. The pH of the solution 
containing the desorbed dye was adjusted to pH 3 by adding 1% v/v of 12.3 M HCl. The 
absorbance of the solution was then measured at 484 nm. 
3.2.2.8 Immobilization and quantification of epidermal growth factor (EGF) on nanofibers 
EGF grafting on amine-functionalized nanofibers 
Aminolysed nanofibers were reacted with a freshly prepared Bis-N-succinimidyl-
(pentaethylene glycol) ester (Bis(NHS)PEG5) linker, i.e. 2.5 mM Bis(NHS)PEG5 in 10-mM 
phosphate buffer (PBS) containing 1% Dimethyl sulfoxide (DMSO) for 45 min at RT. The mats 
were intensively rinsed in PBS to remove any unbound linker. The PEG-covered nanofibers were 
then NHS-reactivated with a 50:50% v/v mixture of N-Hydroxysuccinimide (NHS) (0.1 M in 
Milli-Q water) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (0.4 M in Milli-Q 
water) for 15 min at RT. After rinsing with Milli-Q water, the mats were reacted with 100 nM 
EGF in PBS for 1 h at RT and rinsed with PBS. Unreacted NHS groups were blocked using 1 M 
ethanolamine (pH 8.5) followed by a rinsing step (PBS). 
EGF density quantification via Enzyme-Linked Immunosorbent Assay 
(ELISA)  
Quantification of covalently bound EGF was based on previously reported work.[183] 
Commercially available DuoSet ELISA kit was purchased from Cedarlane (Burlington, ON, Cat. 
# DY236). Circular mats (0.785 cm2) were cut and introduced in a 48-well plate. The mats were 
covered with 300 µL of bovine serum albumin (BSA) solution (1% BSA in PBS, PBS-BSA) for 
15 min to prevent undesired non-specific interactions between the surface and the ELISA 
reagents. After rinsing with a wash solution containing 0.05% Tween 20 diluted in PBS (PBS-T), 
  
37 
300 µL of EGF detection antibody (50 ng mL-1 in PBS-BSA) was added to the wells followed by 
incubation for 1 h at RT. After a second wash with PBS-T, 300 µL of streptavidin-HRP (diluted 
200 times with PBS-BSA) was added to the wells and the solution was incubated for 20 min at 
RT. Following a final wash with PBS-T, the reaction was revealed with 300 µL of substrate 
solution (50:50% v/v hydrogen peroxide/tetramethylbenzidine). After 30 min in the dark, the 
colorimetric reaction was stopped by adding 150 µL of 2 N H2SO4. The solutions were 
transferred to a 96-well plate and the optical density at 450 nm was measured using an ELISA 
plate reader (Victor 3V Multilabel Counter, PerkinElmer Inc.). 
3.2.2.9 PLLA scaffolds characterization 
Structural morphology of PLLA scaffolds 
The topography and morphology of electrospun PLLA scaffolds were characterized using 
scanning electron microscopy (SEM) (JSM 5600, JEOL, Japan) with an accelerating voltage of 
10 kV. The diameters of the fibers were measured from the SEM photographs using an image 
analysis software (ImageJ, National Institutes of Health, USA). Prior to characterization, the 
scaffolds were coated with gold (twice for 15 s) using a sputter coater (JEOL JFC-1200 fine 
coater, Japan).  
Mechanical	  characterization	  of	  PLLA	  scaffolds	  	  
The PLLA fibers were tested according to ASTM D3822 using a 250 N load cell at a 
crosshead speed of 5 mm min-1 and a pressure of 20 psi. Small pneumatic clamps were used to 
grip the individual mats. The sample gauge length used was 1 mm. The Automatic Young’s 
modulus, tensile stress at yield, tensile stress and tensile strain at maximum load were calculated 
using Bluehill software (Instron, Norwood, U.S). Prior to analysis, the mat dimensions were 
recorded and the mat thicknesses were measured using a micrometer. The analyses were 
performed on three to five samples per experimental condition. 
Porosity calculations 
Mat dimensions were measured along each sample and the average values were used for 
calculations. Weight was recorded for each sample. The porosity and the apparent density were 
evaluated according to:  
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                                                                Porosity   % = 1−   apparent  density  (g/cm!)bulk  density  (g/cm!)   ×  100                                                          (1) 
                                                  Apparent  density   gcm! =    mat  mass   gmat  thickness   cm   ×  mat  area   cm!                                     (2)   
where the bulk density of pure PLLA is 1.25 g/cm3. [184]  
Cell culture 
Engineered Neural Stem-Like Cells (NSLC) provided by NewWorld Laboratories Inc. 
(Laval, QC) were cultured in a medium prepared by mixing neural progenitor basal medium 
(NPBM, Cedarlane, Cat. # 3210) with neural progenitor supplement singlequot kit (Cedarlane, 
Cat. # 4242) and neural progenitor maintenance medium (NPMM) singlequot kit. The NPMM kit  
contained recombinant human epidermal growth factor rhEGF and human fibroblast growth 
factor rhFGF (Cedarlane, Cat. # 4241); 0.1 ml of rhEGF and rhFGF were used for cell seeding 
medium. The cell culture medium was supplied as a sterile liquid (containing dextrose); rhEGF 
and rhFGF were supplied in a sterile buffered BSA saline solution. Laminin (Sigma-Aldrich 
Canada Ltd, Cat. # L2020-1MG) was also added as supplement (5 mg L-1) for cell culture. The 
cells were seeded in flasks (Corning CellBIND, Cat. # 3337) and cultivated in a standard 
humidified incubator at 37 °C with 5% CO2 in complete maintenance medium. The cells were 
dissociated with 0.01% trypsin/10 mM EDTA (Lonza, Cat. # 5012) centrifuged and re-suspended 
in medium prior to cell seeding on nanofibers or subculturing. Cells were always used between 
passage 10 and 14. 
Prior to cell seeding, the nanofiber mats were cut into 1-cm diameter disks with a round 
hole-arch punch, dipped in ethanol (70% in Milli-Q water) and exposed to UV for 30 min for 
sterilization. The samples were then placed into polystyrene tissue culture 48-well plates (VWR, 
Cat. # 82050-888) under a sterile laminar hood. Autoclaved glass cylinders (8 mm inner 
diameter) were placed onto the samples. When mentioned, samples were coated with laminin (20 
µg mL-1, Cat. # L2020- 1MG) in PBS for 1 h and then gently washed three times with PBS. Cell 
suspension (1 mL) containing 1.6×104 cells was then added to each well to inoculate the cells on 
nanofibers. The medium (2 mL) was replenished every two days. The cells were incubated within 
either growth factor-free medium (referred to as ‘basal medium’), basal medium + soluble FGF 
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(referred to ‘EGF-free medium’), or basal medium + soluble FGF + soluble EGF (referred to ‘full 
medium’). Note that the pH of the culture medium was an uncontrolled variable. 
Proliferation assays 
Cell counts were performed at different time points, i.e. 2, 6 and 10 days to assess 
adhesion and growth. The cell-seeded samples were first washed with PBS three times and fixed 
in a formaldehyde solution (3.75% w/v in PBS) for 30 min in an incubator. After three additional 
PBS washes, the cells on the nanofibers were stained with SYTOX Green Nucleic Acid Stain (1 
µM in PBS; 300 µL per well; Invitrogen, Burlington, ON, Cat. # S7020) for 15 min in the dark 
then washed again with PBS three times. The stained samples were visualized under a fluorescent 
microscope (Axio Observer Z1, Zeiss Inc.) and images of complete samples were captured using 
the MosaiX acquisition from the AxioVision imaging software (AxioVision, Zeiss Inc.). Cells 
were counted on SYTOX stained images with the software ImageJ, for four different samples per 
group. Note that fluorescence staining was required for these studies due to the opacity of the 
fibers, which prevented normal light observation.  
Phenotype analysis 
To assess cell phenotype, samples were rinsed three times with 1 mL PBS and fixed in 1 
mL formaldehyde (3.7%) during 30 min. Fixed cells were permeabilized using Triton (0.5%, 20 
min). To avoid non-specific adsorption of primary antibodies on PLLA nanofibers, a blocking 
step was performed using normal donkey serum (NDS) in PBS (Sigma-Aldrich, Cat. # D9663-
10ML) for 1h at 5% and 2h at 10% prior to nestin and TUJ-1 immunostaining, respectively. 
Samples were immunostained at 4°C overnight with different primary antibodies: goat anti-nestin 
(Santa Cruz Biotech, Dallas, TX, Cat. # sc-21248) or mouse anti-TUJ-1 (Neuromics, Edina, MN, 
Cat. # MO15013). Primary antibodies were dissolved in 0.1% Triton, 1% NDS in PBS, to reach a 
concentration of 3 µg mL-1. After 3 additional washes, samples were incubated with secondary 
antibodies: donkey anti-goat or goat anti-mouse (Santa Cruz Biotech, Dallas, TX, Cat. # sc-
362265 and sc-362257, respectively) in 1% NDS for nestin stained samples and in 8% NDS for 
TUJ-1 stained samples. After a 1-h incubation, cells were washed in 0.1% Tween/ PBS 3 times 
for 5 min each. At the end, SYTOX green was also added during 15 min at 1 µM to stain nuclei. 
The stained samples were visualized under fluorescent microscope (Axio Observer Z1, Zeiss 
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Inc.) and representative images were captured using the imaging software (AxioVision, Zeiss 
Inc.).   
Statistical analysis 
All data are expressed as means ± standard deviations of experiments carried out at least 
in triplicate. Statistical analysis was performed with a two-way analysis of variance (ANOVA) 
followed by appropriate post-hoc tests (student t-tests and Bonferroni). Data sets were considered 
significant for p values below 0.05.  
3.2.3 Results 
3.2.3.1 Preparation and properties of random PLLA nanofibers  
Many factors influence the diameter and morphology of electrospun nanofibers such as 
polymer concentration, molecular weight of polymer, the applied voltage, flow rate, humidity and 
temperature of the surrounding environment. Some of these conditions were explored to generate 
the nanofibrous mats used in this study (manuscript in preparation). Electrospinning of PLA 
nanofibers mats according to the condition described in the materials and methods section 
allowed for the creation of randomly oriented 3D scaffolds with interconnected pores (see 
Scanning Electron Microscope (SEM) images of pristine mats in Figure 3-2A). The average fiber 
diameter of the nanofibers was determined to be 408 ± 77nm with a porosity of 86.8 ± 1.2 %. 
3.2.3.2 Aminolysis of PLLA nanofibers 
Amine functionalization of the electrospun PLLA nanofibers was performed using two 
aminated polymers, polyallylamine (PAAm, 15 kDa) and polyvinylamine (PVAm, 25 kDa) as 
well as a short diamine molecule, i.e., ethylenediamine (EtDA). The chemical reaction involves a 
nucleophilic acyl substitution where the carbonyl group of PLLA could accept the electron pair 
from the nucleophilic amine functionalities. As a result, covalent amide bonds were formed 
between the PLLA and the amine-containing (macro)molecules, as presented in Figure 3-1. 
Quantification of surface-exposed amine groups was performed using the Orange II dye 
(Table 1), as previously reported.[182] Amine groups were successfully added to the PLLA 
fibers using PAAm (Table 1, conditions B-F). A significant increase in amine density was indeed 
observed when compared to the control samples (condition H: pristine samples immersed in 
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polymer-free solution mixture, i.e. water and dioxane only) for which the surface concentration 
of amine groups was almost zero (0.3 ± 0.1 µmol g-1). PAAm-based aminolysis was performed 
on the PLLA samples for 1, 3, and 20 h at 60 °C and pH 12.5 (condition B, C and D, 
respectively; Table 1 and Figure 3-2). Although the average fiber diameter (AFD) remained 
intact throughout at 448 ± 78 nm (as previously reported for poly(caprolactone) electrospun 
nanofibers after aminolysis [185]), the nanofibers had noticeably degraded after 20 h of reaction 
time as shown in Figure 3-2D. It should be noted that a complete dissolution of the PLLA 
nanofibers was observed for a reaction time of 24 h (data not shown). For reaction time ranging 
from 1 to 3 h, no significant change in amine group density was noticed, i.e. 109.8 ± 23.7 and 
120.3 ± 26.3 µmol g-1 (p = 0.54). PAAm-based aminolysis was also performed at a temperature 
lower than the Tg of the PLLA (ca. 57 °C).[186] Decreasing the reaction temperature from 60 to 
50 °C (conditions B and F, respectively) had no influence on the surface amine group quantity (p 
= 0.20) as well as the AFD (p = 0.20). However, when the pH of the reaction was adjusted to 
11.5 (condition E), a significant decrease in amine group density was observed compared to 
nanofibers reacting at pH 12.5 (condition F), i.e. 88.6 ± 22.7 and 133.2 ± 16.3 µmol g-1 (p < 
0.05), respectively. Of interest, the density of exposed amine groups on PLLA nanofibers via a 
polymer-based aminolysis appeared to be mainly guided by the pH of the reaction mixture, as 
previously observed for PET films [182] and PET fibers.[187] No significant difference in weight 
was observed before and after aminolysis (p = 0.69 and p = 0.34) for PAAm and PVAm 
respectively at 1 h (data not shown).    
In conclusion, the optimal reaction condition for PAAm-based aminolysis providing the 
highest amino group density (133.2 ± 16.3 µmol g-1) with a minimal impact on AFD (p = 0.1) 
and porosity (+ 2.5 %) compared to the pristine mat (condition A) was the condition F, i.e. 
reaction performed at 50 °C and pH 12.5 for 1 h. Furthermore, mechanical testing of these mats 
revealed that, although the Young's modulus of the pristine mats decreased after they had been 
placed in wet conditions (PBS or water and dioxane only), no significant difference was observed 
between the samples after exposure in wet conditions and after aminolysis (data not shown). 
Therefore, the decrease in Young's modulus was probably due to hydration as water is known to 
act as a plasticizer.[188, 189] This decrease in young modulus brings the fiber closer to the young 
modulus in the CNS. [168, 169] A more complete study on the evolution of mat morphology with 
process and material parameters will be published elsewhere (manuscript in preparation). 
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For the sake of comparison, aminolysis was also performed using PVAm and EtDA. 
Under the optimized conditions for PAAm, the PVAm (condition G) was found to be less 
efficient at introducing amino groups to the PLLA nanofibers, giving rise to a density of amino 
group of 76.68 ± 9.84 µmol g-1 without affecting the AFD (p = 0.9) compared to pristine mat 
(condition A). In contrast, when the small EtDA molecule was reacted with PLLA mats 
(conditions J-L), the resulting amino group density remained low (ca. 0.4 ± 0.1 µmol g-1) for 
reaction time varying from 10 to 30 min and was on the same order of magnitude as the negative 
control (condition M: pristine samples immersed in MeOH only, 0.2 ± 0.1 µmol g-1). It should be 
noted that a large degradation of the PLLA mats was observed after EtDA-based aminolysis 
starting from 10 min, as revealed by very poor mechanical properties (data not shown). This 
observation was in agreement with what had been previously observed for PET fibers. [187] 
3.2.3.3 EGF grafting on aminated PLLA mats 
NHS ester functionalized homobifunctional PEG linker (Bis(NHS)PEG5) was used to 
chemically graft human EGF on PAAm-aminolysed mats. EGF grafting was evaluated via direct 
enzyme-linked immunosorbent assay (ELISA, Figure 3-3), as previously proposed.[183] NHS-
reactive functionality of the PEG linker was first reacted with the surface-exposed amine groups 
to create stable amide bonds. Remaining NHS groups were then used to couple human EGF via 
its available amino groups (displayed on lysine residues or at the N-terminus of the proteins). 
After EGF grafting, an ethanolamine-mediated NHS deactivation was applied to prevent 
undesired attachment of other molecules containing amino groups such as the secondary 
antibodies used in the ELISA method. 100 nM of EGF dissolved in 10 mM phosphate buffer (pH 
7.4) was found to be the optimal condition to obtain a dense grafted layer on PEG-functionalized 
mat (data not shown), in agreement with previous work.[156] The resulting EGF layer was 
characterized by an ELISA optical density (O.D.) of 0.774 ± 0.062. As negative control, human 
EGF was incubated on ethanolamine-deactivated PEG (O.D. value of 0.238 ± 0.027). Minor 
variations in O.D. values were noticed between the deactivated PEG layers with or without 
exposure to EGF (-0.023). Furthermore, another negative control was performed with aminated 
mats only. An even lower value (p = 0.033 ± 0.0009) was observed compared to the 
ethanolamine-deactivated PEG layers. This was probably due to the high density of exposed 
amine groups on the PLLA surface being protein-repellent.[80, 190-193] Altogether, these results 
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indicated that EGF was mainly covalently attached thanks to the linker layer and that EGF non-
specific adsorption was negligible. 
3.2.3.4 Cell proliferation assays 
To evaluate the influence of EGF grafting on NSLC proliferation, cells were seeded and 
cultivated on different treated PLLA scaffolds for ten days, while changing the media every two 
days as mentioned in the material and methods section. EGF-grafted PLLA mats were compared 
with their negative controls, namely pristine and aminated mats. To differentiate the bioactivity 
of grafted EGF from that of soluble growth factors present in the medium supplements (i.e., 
soluble EGF and FGF), different media formulations were used: growth factor-free medium 
(referred to as ‘basal’), EGF-free medium (with soluble FGF) and full medium (with both soluble 
FGF and EGF). As positive control, NSLC proliferation was also characterized on laminin-coated 
mats in EGF-free medium. 
When grown in basal medium, the number of NSLC was significantly higher (p < 0.05) 
on EGF-grafted mats than on aminated scaffolds or pristine scaffolds for all three time points 
(i.e., day 2, 6 and 10, see Figure 3-4). These results indicated that randomly grafted EGF 
remained at least partly bioactive, in spite of already documented negative impacts of the random 
amine coupling strategy [156] and still showed its well-known effect on proliferation.[27, 174] 
Similarly, when grown in EGF-free medium, NSLC proliferation was also significantly higher (p 
< 0.05) on EGF-grafted mats than on aminated scaffolds (Figure 3-4).  
Interestingly, NSLC were able to proliferate similarly on EGF-grafted mats in basal 
medium as well as in EGF-free medium, i.e., up to 18447 ± 3480 and 16546 ± 3065 cells at day 
10. Note that NSLC remained very few on aminated mats even at day 10, regardless of the 
presence of growth factors. No significant differences were observed between the EGF-grafted 
mats in EGF-free medium, basal medium and the positive control (laminin-coated mats in EGF-
free medium), p = 0.78 and p = 0.34 respectively.  
Representative fluorescent images taken at day 10 confirmed the high cell density 
observed on EGF-grafted mats, regardless of the medium (Figure 3-5, E to G). An abundance of 
cell clusters was observed on pristine and aminated mats in full media (Figure 3-5B and 5D), 
suggesting that untreated PLLA scaffolds were not optimal to grow NSLC. In stark contrast, cell 
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distribution appeared quite homogeneous on EGF-treated mats in basal media and EG-free 
medium, although a few small clusters were noticeable when cultured in full media (Figure 3-5G, 
arrows). Furthermore, even the positive control, i.e., laminin-coated mat, appeared to have cells 
less spread out compared to EGF-grafted mats.  
Immunostaining was performed on NSLC grown on EGF-grafted scaffolds as well as on 
pristine scaffolds as control, in medium supplemented with FGF only (Figure 3-6). β-III-tubulin 
staining (TUJ-1) showed some neurite outgrowth, which indicated that the cells remained viable 
for up to 14 days of culture on both EGF-grafted and pristine mats, although large clusters could 
be observed on pristine mats. NSLC were positive to nestin staining. The small neurite extensions 
visible for both experimental conditions as well as the lack of large cellular network indicated 
that the cells remained pluripotent.  
3.2.4 Discussion 
PLLA nanofiber mats were produced by electrospinning, as biodegradable and highly 
porous (86.8 ± 1.2 %) scaffolds suitable for nerve regeneration. To improve NSLC growth onto 
these scaffolds, surface functionalization (amination) was performed. Our strategy was to bring 
reactive moieties onto PLLA electrospun mats to subsequently graft relevant cell-signaling 
molecules, thereby tailoring our PLLA scaffold. To control the identity and quantity of added 
functional groups, wet chemistry aminolysis was used. This technique allows for the addition of 
amine functional groups while limiting the degradation of PLLA. We have already reported a 
non-damaging method for amination of polyethylene terephthalate (PET) materials, based on the 
use of polyvinylamine (PVAm), which could be applied to create reactive amino groups at the 
surface of PLLA nanofibers.[187] Due to the degradable nature of PLLA, it can be quite difficult 
to preserve its topography and bulk integrity while functionalizing it, even via wet chemistry 
aminolysis. The aforementioned chemical treatment was therefore adapted to our highly 
degradable polyester by decreasing the initial reaction time and temperature (i.e. 24 h at 70°C) to 
1 h at 50°C as well as degassing the solution prior to experiment, illustrating the differences in 
degradability of PET and PLLA. As previously reported, the pH was found to be a critical 
parameter as basic conditions are needed for the aminolysis to occur, via the unprotonated 
primary amines of the PVAm.[187] In our study, polyallylamine (PAAm) was used instead of 
PVAm because of their strong similarities (one additional carbon on the side chains of PAAm) 
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and the lower cost of PAAm. Compared to the commonly used ethylenediamine (EtDA) the 
polymer-based aminolysis allowed us to mostly preserve the physical properties of the 
electrospun mats, i.e. porosity and fiber diameter, without any noticeable change on SEM images.  
Epidermal growth factor (EGF), that is known to promote cell proliferation, was then 
grafted onto the available amino groups of PAAm-functionalized PLLA mats. A PEG molecule 
was used as both spacer and chemical linker between PAAm and EGF amino groups. This 
grafting strategy proved to be both efficient and specific as negligible non-specific adsorption of 
EGF was observed.  
To evaluate the bioactivity of our EGF-grafted mats, an extensive proliferation study was 
carried out on various modified PLLA mats in various media. When soluble growth factors were 
present in the medium, NSLC were able to proliferate on pristine PLLA mats, however, they 
tended to form cell clusters (Figure 3-5B and supplementary data Figure S1), an indication of 
their low affinity for the hydrophobic substrate. Their high cell proliferation rate and density 
were most likely due to the many cell clusters that had started to form at day 6 (Supplementary 
data Figure S1-C).[194-197] EGF-immobilization on PLLA highly supported cell proliferation 
compared to pristine PLLA mats. Our functionalization of PLLA mats with EGF not only 
provided the cells with a substrate harboring proliferative cues but may have also modified the 
surface properties of the PLLA mat to make it more suitable for cell adhesion and growth without 
greatly affecting its surface topography. As the first step towards EGF grafting, PLLA mats were 
modified with PAAm aminated polymer, thereby switching surface properties from hydrophobic 
to hydrophilic. However, aminated PLLA scaffolds showed very low NLSC adhesion and 
proliferation, with a slower growth than that observed on pristine PLLA mats (Figure 3-4). Such 
a behavior has been previously reported on surfaces coated with cationic polymers [190], 
suggesting that PAAm coating most probably provided the mats with inadequate surface 
properties such as a high positive charge and a very high hydrophilicity. Indeed, surfaces with 
moderate wettability (neither too hydrophobic nor too hydrophilic) are desirable for good cell 
adhesion and positive cell response. [80, 181, 190-192] Coatings that were too hydrophilic were 
shown to prevent proliferation as well as adhesion of both proteins and cells, such is the case for 
dense PEG coatings.[191, 198, 199] That hypothesis is supported by our data for the first time 
point of our proliferation study (Figure 3-4, day 2), which was mostly representative of adhesion, 
considering that the NSLC have a doubling time of 37 hours. On aminated mats, NSLC adhesion 
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levels were indeed quite low, regardless of the presence of growth factors in the media, that is in 
basal medium, EGF-free medium and full medium (6340 ± 1403, 5469 ± 1068 and 4721 ± 400 
cells, respectively). Cell adhesion being mostly driven by protein adsorption, our results suggest 
that PAAm-modified mats were indeed protein-repellent, unlike pristine mats onto which cells 
adhered better in full medium (9718 ± 264 cells) than in basal medium (3491 ± 1259 cells). 
Another report stated that PAAm may not prevent cell growth per se but could hinder cell 
spreading and consequently proliferation.[193] 
The amino groups available on the PAAm-coated mats were used to graft EGF via a PEG 
linker. That full functionalization proved to be beneficial right from cell adhesion, be it in basal 
medium, EGF-free media or full media (11327 ± 1233, 9696 ± 1436 and 9187 ± 1037 cells, 
respectively, at day 2, see Figure 3-4). That additional layer of molecules most probably hid part 
of the PAAm hydrophilic background, thus promoting cell adhesion in a similar fashion to 
adsorbed proteins, in addition to providing the cells with a pro-proliferative cue, i.e., grafted 
EGF. The bioactivity of grafted EGF per se was also demonstrated since NSLC were able to 
proliferate on EGF-modified scaffolds at rates similar to our positive control (Figure 3-4), and 
remained viable up to day 14 by maintaining multipotent NSC in a proliferative state (as 
evidenced by the nestin expression) (Figure 3-6). Of interest, grafted EGF promoted NSLC 
growth in the absence of soluble growth factors as well as in synergy with soluble FGF. This 
shows that immobilization of EGF improved the poor ability of PLLA to support cell adhesion 
and proliferation. The increased number of cells results from the accelerated cell growth and can 
also be attributed to the high mitogenic activity related to the presence of EGF. Therefore, 
culturing NLSC on EGF-grafted nanofibers could be used to maintain the self-renewal and 
stemness of these cells. It has been reported that tethered EGF enhance cell proliferation when 
compared to its soluble version, more likely because this mode of presentation increases EGF 
density at the cell surface [144], which in turn may prolong receptor phosphorylation and 
signaling pathway activation.[30]   
Of salient interest, when the medium was supplemented with soluble EGF in combination 
to grafted EGF, cells formed clusters at day 10 (Figure 3-5G). These clusters were also observed 
on aminated mats in full medium at days 6 and 10 (Supplementary data Figure S1- B & E) as 
well as for pristine mats in full medium (Supplementary data Figure S1- C & F). Previous studies 
have shown that A431 cell clusters could form as concentration of EGF in medium is increased. 
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[200] Therefore, although our EGF-grafted scaffolds were able to promote significant NLSC 
proliferation, a grafted-EGF density-dependent study should be carried out to further optimize 
our strategy.  
Randomly oriented covalent immobilization of EGF through its reactive amine groups 
present at the N-terminus or on its lysine chain are the most common method used [30] as was 
performed in this study. This method, however, may not be the most optimal strategy as it can 
negatively impact protein conformation, relative molecular orientation, and spatial homogeneity, 
leading to diminished bioactivity.[30, 156, 157, 201, 202] Therefore, for improved bioactivity, 
EGF may be tethered to our PLLA scaffold in an oriented fashion, e.g. as described elsewhere. 
[24, 156, 203, 204] Furthermore, the progenitor cells may be promoted to differentiate to specific 
and appropriate lineages. Binan et al have reported the differentiation of neural stem cells into 
motor neurons using electrospun PLLA/gelatin scaffold.[205] In their approach, NSLC were 
seeded onto scaffolds releasing, retinoic acid and purmorphamine. These scaffolds were shown to 
enhance the differentiation of NSLC into motor neuronal lineage as well as promote neurite 
outgrowth. The combination of both approaches onto a structure releasing retinoic acid and 
purmorphamine while displaying tethered EGF may thus be promising. 
3.2.5 Conclusion 
In this study, we report the successful surface functionalization of Poly L-lactic acid 
(PLLA) electrospun nanofibers with amine groups while maintaining the overall mechanical and 
structural properties of the scaffold without any changes in average fiber diameter (AFD). Further 
scaffold modifications allowed to covalently immobilize EGF onto PLLA fibers in a two-step 
process: surface aminolysis followed by conjugation of EGF via a PEG linker. Cell culture 
studies clearly demonstrated that EGF enhanced cell viability by maintaining multipotent cells in 
a proliferative state, which was supported by fluorescence microscopic images. With this 
information, EGF immobilization on nanofibers could be a promising avenue to design scaffolds 
for neural stem cell-based regenerative medicine applications. 
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3.2.8 Figures 
 
Figure 3-1: PLLA aminolysis reaction involving (A) polyallylamine (PAAm) and (B) 
ethylenediamine (EtDA). 
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Figure 3-2: SEM imaging of (A) pristine and (B-D) PAAm-treated PLLA nanofibers. PAAm 
grafting was carried out at pH 12.5 and 60 deg. C for (B) 1 h, (C) 3 h, and (D) 20 h. 
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Figure 3-3: Characterization of the EGF grafting on PLLA nanofibers by direct ELISA. Optical 
densities (O.D.) corresponding to PAAm-covered mats treated with (a) PEG linker, EGF and 
ethanolamine (for deactivation of unreacted PEG). Mats covered with PEG linkers that were 
deactivated before EGF incubation (c) or without any EGF incubation (d) were used as negative 
controls. As reference, the O.D. value obtained on (d) unmodified PAAm-covered mats is 
presented. Statistical differences are noted ** (p < 0.01). Experiments were performed using four 
samples (n = 4). 
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Figure 3-4: NSLC proliferation on pristine, PAAm-grafted, EGF-grafted and laminin-coated 
PLLA mats. Cells were exposed to basal medium (denoted ‘-’) or basal medium supplemented 
with FGF only or a mix of FGF and EGF. Statistical differences noted * correspond to p < 0.05 
(n = 3). 
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Figure 3-5: Fluorescence microscopy images of NSLC after 10 days of cell culture onto various 
surfaces. Scale bars correspond to 400 µm. 
 
 
 
 
 
Pristine!
-! FGF / EGF!
PAAm!
-! FGF !
Grafted EGF!
-! FGF! FGF / EGF!
Laminin!
FGF !
B!A! C! D!
E! F! G! H!
2.5x 
4x 4x 
  
56 
 
 
 
 
Figure 3-6: Fluorescence microscopy images of NSLC at days 5 (A-D) and day 14 (E-H) in 
culture on nanofibers with grafted EGF or pristine nanofibers. Scale bars correspond to 100 µm. 
 
 
 
 
 
 
 
2.5x 
2.5x 
2.5x 2.5x 
  
57 
3.2.9 Table 
Table 1. Properties of pristine and aminolysed PLLA nanofibers. 
 Treatment pH Reaction time 
Reaction 
temperature (°C) 
Average Fiber 
Diameter (nm) Porosity  
Amine group 
density (µmol g-1) 
A Pristine    408 ± 77 86.8 ± 1.2  
B 
PAAm 
12.5 1 h 60 407 ± 62  109.8 ± 23.7 
C 12.5 3 h 60 474 ± 69  120.3 ± 26.3 
D 12.5 20 h 60 461 ± 94  N/A 
E 11.5 1 h 50 465 ± 114 88.5 ± 1.0 88.6 ± 22.7 
F 12.5 1 h 50 472 ± 59 89.4 ± 0.9  133.2 ± 16.3 
G PVAm 12.5 1 h 50 414 ± 119 88.0 ± 0.9 76.7 ± 9.8 
H  Control                
(water + dioxane) 
   Control                 
(water + dioxane) 
1 h 60 428 ± 68  0.3 ± 0.1 
 
I 
 
1 h 
 
50 
 
420 ± 85 
 
84.6 ± 1.2 
 
0.4 ± 0.1 
J 
EtDA 
 10 min 50   0.3 ± 0.1 
K  20 min 50   0.4 ± 0.1 
L  30 min 50   0.3 ± 0.1 
M  Control 
 (MeOH only) 
20 min 50    0.2 ± 0.1 
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CHAPITRE 4 GENERAL DISCUSSION  
The fabrication and surface modification of poly L-lactic acid via aminolysis and EGF 
grafting were developed in this work. This optimization step was then followed by the 
investigation of its effect on NSLC adhesion, proliferation, and cell viability.  
The desired topology include high porosity (higher than 80%) [85], and nano-metric fiber 
diameters. [16] An ideal fiber thickness would be lower than 150-200 µm [121, 123] and 
mechanical strength closer to the human brain (0.00015MPa-0.01MPa)[168, 169]. Yang et al [16] 
have shown that the rate of NSC differentiation was higher for PLLA nanofibers than 
microfibers. Also, studies have shown that smaller fiber diameters, high porosity, and suitable 
mechanical properties of the substrates enhanced cell proliferation effectively. [206] Nanometric-
scale fibers have also shown to enhance cell proliferation and spreading. [16, 37] A high porosity 
of a scaffold increases the water adsorption of the scaffold and enhances the cell attachment, 
proliferation, and differentiation of cells. [207, 208] Our own results, presented in the appendix, 
also showed that the optimal topology is an aligned oriented nanofiber; they demonstrate 
superiority in cell adhesion and cell proliferation.  
In this study some experimental challenges were faced; challenges during the 
electrospinning process included high ambient humidity and temperature as well as dust (i.e. 
from dessicants). The high ambient humidity causes beads as shown in Appendix C (Figure C3). 
To maintain the relative humidity between 20-30%, dessicants (Drierite ®) were placed inside 
the electrospinning experimental set-up. The formation of dust on the fibers (Figures C1&2) 
should be decreased as much as possible as they could pose potential problems on cell culture 
assays (even after intensive sterilization procedures) such as the interference of cell attachment 
on the fibers. Therefore, on top of placing samples directly in dessicators at all times, dessicant 
dust should be avoided by transferring under the fume-wood while allowing dust to settle 
completely prior to placement in electrospinning set-up.  
Other experimental challenges included a large amount of solution dripping from the 
needle tip, resulting in a low amount of polymer solution jet reaching and forming fibers on the 
collector. Therefore, the process was optimized, by varying the electrospinning conditions to 
achieve the desired AFD and fiber thickness. Notably, after various trial conditions, the tip-
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collector distance was decreased from 15 to 10 cm and the voltage increased from 15kV to 23.75 
kV. Some solution dripping was still observed but was greatly decreased.  
Therefore, the fabrication of PLLA fibers using electrospinning with high porosity (86.8 ± 
1.2 %) in the nanometric range (408 ± 77 nm) and fiber thickness in the range of 97 ± 20 µm was 
used for the random nanofibers was used in this study.    
The rationale for our technological choices is as follows: The electrospinning technique 
was used because it creates nanofibers that resemble the extracellular matrix of the host tissue in 
terms of porosity, structure, topography, and interconnecting pores. [10, 89]  
An aminolysis reaction (for amine functionalization on PET films) reported by Noel et al 
[31] was optimized and utilized in order to attach amine moieties onto the PLLA substrate. The 
aminolysis reaction was adapted from the afore-mentioned protocol due to the fragility of 
electrospun PLLA. The sonication process had degraded the PLLA nanofiber while the presence 
of bubbles on the fiber’s surface still remained. Therefore, in order to remove the formation of 
bubbles on the fiber’s surface, the solution mixture was degassed under vacuum for 20 mins 
while stirring, prior addition to PLLA. Furthermore, the experimental temperature was decreased 
from the initial reaction time and temperature (i.e. 24 h at 70°C) to 1 h at 50°C.  
In conclusion, the substrate remained physically intact, the AFD and porosity remained 
unchanged following successful amine functionalization. This is in stark contrast with amination 
protocols relying on plasma treatment that has been reported to degrade PLA [15] or aminolysis 
using the small molecule ethylenediamine. A PEG linker was then used to covalently couple EGF 
via its free amines to the amines introduced onto the PLLA structure via aminolysis.  
Cell culture assays revealed that cells grown on substrates grafted with EGF were still 
viable up to 14 days. No differences were observed for neural stem character, with and without 
EGF surface modification. Furthermore, cell adhesion and proliferation was improved when 
substrates were grafted with EGF, when compared to substrates that were only aminated. In this 
work, the functionalization of PLLA mats with EGF not only provided the cells with a substrate 
harboring proliferative cues but may have also modified the surface properties of the PLLA mat 
to make it more suitable for cell adhesion and growth. As positive control, NSLC proliferation 
was also characterized on laminin-coated mats in EGF-free medium where no significant 
differences in cell proliferation were observed between the EGF-grafted substrates and the 
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positive control. Note that it was not possible to determine which cells in the histology were in 
contact with PLLA fibers (with or without EGF modification) due to technical limitations in the 
ability to visualize the scaffold nanofibers by optical or epifluorescence microscopy. Therefore, 
this new functionalized and EGF-grafted biomaterial has achieved efficient cell adhesion, 
proliferation as well as cell viability up to 14 days and has promising use in stem cell 
regeneration therapy.  
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CONCLUSION 
Electrospun PLLA nanofibers have promising potential in neural tissue engineering. This 
work proposes an efficient method of manufacturing a graft structure for implantation and 
subsequent regeneration of damaged cells in the CNS. This work describes an optimized method 
and efficiency of the surface modified structure on cell adhesion, proliferation and viability 
without the need of direct injection of growth factors or stem cells and without the need of 
multiple surgeries. Firstly, the aminolysis method was optimized to sufficiently add amine 
moieties without affecting the average fiber diameter, porosity while maintaining the nanofiber 
physically intact. Secondly, EGF was successfully immobilized via the PEG linker and showed 
improved cluster-free cell adhesion and proliferation compared to the negative controls (pristine 
and aminated fibers).  No significant difference was observed for cell adhesion and proliferation 
between the positive controls (laminin coated fibers) and EGF-grafted fibers in EGF-free and 
basal medium, however, the cells were less spread out on the positive controls compared to the 
EGF-grafted fibers. Therefore, we can conclude that EGF-grafted fibers are a successful 
optimized strategy for neural tissue regeneration.    
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PROPOSED IMPROVEMENTS - FUTURE WORK DIRECTIONS 
Future developments could include i) a grafted-EGF density-dependent study, ii) tethering 
EGF to the PLLA scaffold in an oriented fashion for improved bioactivity, and iii) the study of 
the differentiation of the progenitor cells to specific and appropriate lineages. 
i) Grafted-EGF density-dependent study: 
The cell proliferation results showed that cells formed clusters at day 10 when seeded 
onto PLLA grafted with EGF in the presence of medium supplemented with soluble EGF as well 
as FGF (full medium). Clusters were also observed on aminated mats as well as pristine mats in 
full medium at days 6 and 10. Previous studies have shown that A431 cell clusters could form as 
concentration of EGF in the medium is increased.[200] Therefore, although our EGF-grafted 
scaffolds were able to promote significant NLSC proliferation, a grafted-EGF density-dependent 
study should be carried out to further optimize our strategy. This can be done by increasing or 
decreasing the amount of grafted EGF and observing its effect on cell culture assays. 
ii) Tethering EGF to the PLLA scaffold in an oriented fashion for improved bioactivity: 
 Randomly oriented covalent immobilization of EGF through its reactive amine groups 
present at the N-terminus or on its lysine chain is the most common method used [30] as was 
performed in this study. This method, however, may not be the most optimal strategy as it has 
been shown to negatively impact protein conformation, relative molecular orientation, and spatial 
homogeneity, leading to diminished bioactivity. [30, 156, 209] Boucher et al [210] have shown 
that epidermal growth factor receptor (EGFR) phosphorylation was more intense with coiled-coil 
oriented EGF with higher initial A-431 cell adhesion compared to randomly coupled EGF.  
Lequoy et al [183] have also shown that higher EGF surface densities were obtained when 
oriented tethering of EGF was used compared to covalent EGf tethering, while using much lower 
concentrations of EGF during incubation. For improved bioactivity, EGF may be tethered to our 
PLLA scaffold in an oriented fashion using the k/e coil peptide strategy. The PLLA nanofibers 
can be attached to a k-coil peptide via a PEG linker (specifically, NHS-PEG4-Maleimide cross-
linker). The cysteine-tagged k-coil can then link to e-coil via the cysteine as previously reported. 
[156] Finally, e-coil peptide can be attached to EGF via a glycine linker. [156] 
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iii) Differentiation of the progenitor cells to specific and appropriate lineages: 
Furthermore, the progenitor cells may be promoted to differentiate to specific and 
appropriate lineages. Binan et al have reported the differentiation of neuronal stem cells into 
motor neurons using electrospun PLLA/gelatin scaffold. [205] In their approach, NSLC were 
seeded onto scaffolds releasing retinoic acid and purmorphamine. These scaffolds were shown to 
enhance the differentiation of NSLC into motor neuronal lineage as well as promote neurite 
outgrowth. The combination of both approaches onto a structure releasing retinoic acid and 
purmorphamine while displaying tethered EGF may thus be promising. 
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APPENDIX A – TOPOLOGY OPTIMIZATION OF PLLA SCAFFOLDS: 
FIBER ORIENTATION AND BEAD PRESENCE 
Effect of fiber topology on cell proliferation: 
Previous research has been performed on aligned and random fibers where aligned fibers 
demonstrated superiority at mediating interaction between the NSLC and the scaffolds. Neurite 
outgrowth and NSC differentiation are also greatly improved on aligned nanofibers compared to 
other electrospun fibers such as microfibers and random nanofibers. [211]    
There are various contradicting studies on whether NSLC show improved alignment on 
aligned or random cells.  Some studies have shown that neurites extended along the axis of fiber 
when cultured on aligned nanofibers whereas no specific directionality was observed when 
cultured on random nanofibers. [212] In contrast, some studies reported neurites growing in a 
perpendicular manner to the main direction of fiber alignment, with poor penetration of neurites 
inside the structure. [213] Neural stem cells were also tested on aligned and random collagen 
nanofiber scaffolds, where cell proliferation was found to be higher on the aligned fibers. [214] 
Zhong et al [215] have compared aligned and random collagen scaffolds that had been 
crosslinked with glutaraldehyde on cell culture assays of rabbit conjunctiva fibroblasts. Results 
showed that although aligned scaffolds demonstrated lower cell adhesion, higher cell 
proliferation were observed compared to random scaffolds. Wang et al [216] have also shown 
that spinal cord derived neural progenitor cells (NPCs) had expanded faster on aligned nanofibers 
compared to random nanofibers. Other studies, on the other hand, have shown higher cell 
proliferation on random scaffolds compared to aligned scaffolds. Gupta et al [217] have 
compared aligned and random nanofibrous substrates for the in vitro culture of Schwann cells for 
neural tissue engineering. Their results have shown an increase of Schwann cell proliferation on 
random PCL/gelatin nanofibrous scaffolds compared to aligned PCL/gelatin nanofibrous 
scaffolds. Furthermore, Jahani et al [218] have demonstrated higher cell proliferation of 
mesenchymal stem cells on plasma treated and randomly oriented poly-C-caprolactone nanofiber 
scaffolds than on aligned orientation of the same scaffold.  
Corey et al [219] have also demonstrated that aligned electrospun fibers provide a main 
direction for the growth of neurites from spinal root ganglia to neurons. This property would 
allow axons to align to reproduce the nerve structure. In addition to aligning neurites, the neurite 
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extension are also 20% longer on highly aligned fibers and 16% longer on partially aligned 
fibers, compared to random fibers. 
In this project, aligned, random as well as beaded nanofibers were fabricated and their 
effect on cell proliferation compared.   
Methodology  
Sample preparation for cell seeding 
	   The nanofiber mats were cut into 1.5 cm diameter disks with a round hole-arch 
punch, dipped in ethanol (70% in Milli-Q water), and further sterilized by UV exposure for 30 
mins. The samples were then immersed in polystyrene tissue culture 24-well plates (VWR, Cat. # 
82050-888) in quintuplicate under a sterile laminar hood. Autoclaved Glass cylinders (1.3/1.5 cm 
in inner/outer diameters) were placed onto the samples.  The samples were coated with laminin 
(20 µg/ml) in PBS for one hour and then gently washed three times with PBS.   
Cell seeding 
 Cells were diluted to 10,000 cells /ml and added to each well (1ml) (VWR, Cat.# 
82050-888).  As control, the cells were also cultured directly on laminin-coated Tissue Culture 
Polystyrene TCPS (Corning® CellBIND® 24 -Well Product #3337).  An additional 1ml of 
culture medium were added to all wells.  The test plates were incubated for 2, 5, and 10 days and 
the culture medium was replenished (2ml) every 48 hours. 
Results  
Different structures of electrospun nanofibrous scaffolds were fabricated under different 
parameters, characterized to have average fiber diameters of 350 ± 60 nm, and mat thickness 60 ± 
9 µm before being compared in cell cultures.  Porous, nano-scaled fibrous structures were 
revealed for the random, aligned, and beaded nanofibers as shown in the SEM images below.     
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Figure A1: SEM images of different electrospun nanofiber structures from top left to right: 
random, aligned (image expanded), and beaded. Bottom image: aligned nanofibers. 
 
 
Table 2: Average fiber diameter (AFD) and porosity for aligned, random, and beaded nanofibers 
Nanofiber AFD (nm) Porosity (%) 
 
    
Aligned 323.2 ± 51.8 85.2 ± 2.5 
Random 380.1 ± 60.7 83.8 ± 0.6 
Beaded 320.5 ± 81.4 83.0 ± 0.6 
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Figure A2:	   Representative images of cell proliferation assays at day 10 for laminin-coated 
aligned (A), random (B), beaded (C) nanofibers and TCPS (D)  
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Figure A3: Impact of nanofiber structures on cell proliferation 
The different nanofiber structures shown in figure A1 were tested for their effects on 
NSLC proliferation. All of the samples were coated with laminin and as can be seen in figure A3, 
higher cell proliferation was observed on the aligned fibers; the cells are also more spread out 
compared to the other nanostructures as well as the laminin-coated TCPS control group. The cells 
cultured in the laminin-coated control wells (Cellbind) proliferated at the same rate as the random 
and beaded nanofibers due to the 2D surface, however, a higher number (and larger aggregates) 
formed in the control wells compared to the aligned nanofibers due to poor surface contact and 
biocompatibility. Cell adhesion was also higher for aligned nanofibers as shown at day 2. 
Furthermore, figure A4 shows that when coated with laminin, cell adhesion is improved; cells are 
also more spread out and less likely to form clusters. 
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Figure A4: Un-coated and laminin-coated random nanofibers at day 1   
Discussion 
In this paper, aligned, random, and beaded fibers were compared where NSLC 
proliferation on aligned nanofibers were found to be higher (P<0.05) than random and beaded 
fibers as well as the control group (with less cell clusters as well).   
Cell culture protocol used in this study was optimized from previous protocols as 
experimental challenges were faced. Firstly, cell death was observed; in order to avoid cell death 
in future experiments, 2 ml of media was used in the 24-well plates and changed every 2 days (as 
opposed to 1 ml of media changed every 2 days).    
Secondly, the NSCs were proliferating at an alarming rate where cells had already reached 
their maximum confluence on the nanofibers at day 5, rendering comparisons very difficult. The 
amount of growth factors in media was decreased (from 0.4 ml to 0.1 ml); the number of cells 
seeded was also decreased from 50,000 to eventually 10,000 cells per well. Laminin 
concentration was also increased from 10 to 20 µg/ml in order to prevent clusters that had formed 
at 10 µg/ml. 
The results of this study demonstrated that NSCs indeed prefer aligned fibers, consistent 
with the general literature. It has been shown in literature that some filament-like structures 
extend out from the NSLC cell body and neurites to attach to the nanofibers whereas no filament-
like structure of NSLC had been observed on random fibers. It has been postulated that the fiber 
alignment may have an effect on the interaction between NSLC and  scaffolds. [16] These are 
referred to focal adhesions (structurally defined adhesion sites) between the cells and the ECM. 
[89] If cells have superior neurite outgrowth and interaction with scaffolds of aligned nanofibers, 
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then it can be postulated they would induce higher proliferation as well, as was shown in this 
paper.  
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APPENDIX B-SUMMARY OF GROWTH FACTORS 
Table 3: Summary of some growth factors in neural tissue engineering 
Growth 
factor Effect 
Phenotype 
or Pathway 
Delivery 
technique Species Ref 
BDNF 
- Modulates brain elasticity and 
coping of environmental stimuli 
N/A Intraventricular administration Rat 
[48] 
[51] 
[18] 
- Promotes proliferation and 
migration of pluripotent brain cells 
- Increases number of neurons in 
the adult olfactory bulb, striatum, 
septum, thalamus, and 
hypothalamus 
- Prevents degeneration of the red 
nucleus cell body in the brainstem 
- Enhances myelination 
  - p75NTR 
pathway for 
cell death 
Injection Rat [220] 
- Inhibits migration 
- RhoA/ 
Rho kinase 
pathway  
CNTF Prevents degeneration and supports survival of motoneurons 
Embyronic 
motoneuron Injection Rat 
[48] 
[221] 
GDNF 
Increases number and survival of 
motoneurons, regulates 
proliferation and differentiation  
Embyronic 
motoneuron 
Ras-MAP 
and PI3 
kinase 
pathyways 
N/A Chick [52] 
EGF 
Promotes proliferation, 
differentiation and migration of 
NSCs 
Neural stem 
cell 
Tethered on 
scaffold Mouse 
[24] 
[29] 
[30] 
FGF-2 Maintains cell viability, increases cell proliferation N/A 
Soluble 
(addition to 
medium, in vitro 
Rat [45] [37] 
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Growth 
factor Effect 
Phenotype 
or Pathway  
Delivery 
technique Species 
Ref 
 
NGF Promotes choline acetyltransferase in forebrain Motoneuron Injection human [18] 
NT-3 
- Neuronal survival and 
differentiation 
Cortical 
neurons 
(Embryonic 
rat somato-
sensory 
cortex cells) 
N/A Rat [222] 
- Increase synaptic activity at 
the amphibian neuromuscular 
junction, increases frequency 
of action potentials, 
synchronizes excitatory 
synaptic activities in neurons 
- Inhibits γ-aminobutyratergic 
synaptic transmission 
NT-4/5 
- Prevents atrophy of neurons 
Rat 
rubrospinal 
neuron 
N/A Rat [51] - Stimulates GAP-43 and 
Talpha1-tubulin mRNA 
expression 
VEGF 
- Supports neuronal migration 
N/A 
Intraventricular 
pump 
implantation 
Mouse [223] 
- Promotes neurogenesis 
- Has trophic effects on 
neurons and glia 
- Essential for neuroprotection 
& neural patterning 
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APPENDIX C - SEM IMAGES 
      
Figures C1 & 2: An (extreme) example of a fiber covered with dust 
 
Figure C3: Formation of unwanted beads and thinning of fibers due to high ambient humidity 
 
Figure C4: Fusion of fibers due to high ambient humidity 
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Figure C5: Extracellular matrix (red), nerves and nerve bundles (yellow), and ganglion cells 
(blue). [224] 
Supplementary Data: 
 
Figure S1: Fluorescence microscopy images of grafted EGF, aminated and pristine mats in 
growth factors at day 6 and 10. Scale bars correspond to 400 µm. 
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